The Human Body

This site is all about human body. From basics to higher levels. It is equally useful to children as well as professionals.

Google search


Any of the diseases that affect the human digestive tract are the diseases of digestive system. Such disorders may affect the esophagus, stomach, small intestine, large intestine (colon), pancreas, liver, or biliary tract. A prevalent disorder of the digestive system is gastroesophageal reflux disease (i.e., the passage of gastric contents into the esophagus), which causes heartburn on a regular basis in some individuals. Cirrhosis of the liver primarily results from excessive alcohol consumption, but it may also develop after infection with the hepatitis C virus. Other common diseases of the digestive system include peptic ulcers, colorectal cancer, and gallstones. Many disorders of the digestive system can be prevented by a diet low in fats and high in fruits and vegetables, limited alcohol consumption, and periodic medical examinations.

This article discusses the common infections, inflammations, ulcers, and cancers that affect each organ of the digestive tract. For a detailed discussion of the anatomy and physiology of the digestive system, see digestive system, human.


1.MOUTH AND ORAL CAVITY

Besides local disease, features characteristic of systemic disorders are often present on the mouth and in the oral cavity. The lips may be fissured and eroded at the corners in riboflavin deficiency. Multiple brown freckles on the lips associated with polyps in the small intestine is characteristic of Peutz-Jeghers syndrome. Aggregates of small yellow spots on the buccal mucosa and the mucosa behind the lips due to the presence of enlarged sebaceous glands just below the mucosal surface indicate Fordyce disease.

The most common mouth ulcers are due to aphthous stomatitis. These ulcers affect one out of every five Caucasians. The manifestations of this condition range from one or two small painful vesicles rupturing to form round or oval ulcers, occurring once or twice a year and lasting seven to 10 days, to deep ulcers of one centimetre (about half an inch) or more in diameter. The ulcers are frequently multiple, occur anywhere in the mouth, and may persist for months at a time. Symptoms range from a mild local irritation to severe distressing pain that prevents talking and eating. Scarring can be seen at the sites of previous ulcers. Aphthous ulceration is sometimes associated with stress, but it may also be a reflection of an underlying malabsorptive disease such as celiac disease. Treatment is directed to the predisposing cause. Topical and systemic corticosteroids are the most effective treatment. Local anesthetic agents and analgesics may permit easier talking and eating. In a more serious condition, Behçet syndrome, similar ulcers occur in the mouth and on the genitalia, and the eyes may become inflamed.

Discoloration of the tongue, commonly white, is due to deposits of epithelial debris, effete (or worn-out) bacteria, and food. It also occurs in circumstances in which there is reduced saliva production. This may be acute, as in fever, when water loss through the skin is excessive. Discoloration of the tongue becomes chronic following atrophy of the salivary glands and in the absence of good oral hygiene. If the person is a heavy smoker, the deposit is coloured brown. Black discoloration of the tongue with the formation in the centre of a dense pellicle of furlike filiform papillae (black hairy tongue) may be due to a fungus with pigmented filaments. Occasionally it simply represents excessive elongation of the filiform papillae.

A bald tongue (atrophic glossitis), with a smooth surface due to complete atrophy of the papillae, is associated with malnutrition, severe iron deficiency anemia, pernicious anemia, and pellagra, a disorder of skin and mucous membranes due to niacin deficiency. The condition is endemic in underdeveloped countries in which there are periods of famine.

A deeply fissured tongue (scrotal tongue) may be due to a congenital variation in the supporting tissue of the tongue, but it can be caused by syphilis, scarlet fever, or typhoid fever. There is a mild degree of inflammation in the fissures, which causes a slight burning discomfort.

Geographic tongue, or migrating exfoliative glossitis, describes areas of denudation of the surface of the tongue of various shapes and sizes. These areas gradually become re-epithelialized with regrowth of the filiform papillae, only for the inflammatory process to begin elsewhere in the tongue. Thus, the bald zones move around the tongue. These changes usually give rise to no symptoms or, at the most, to a mild burning sensation. The cause is unknown, and the condition may persist for years. There is no treatment.

Vincent disease (trench mouth) is an ulcerating, necrotizing infection of the gingiva (gums) characterized by spontaneous bleeding from affected areas and foul odour of the breath arising from the gangrenous tissue. It is endemic in countries where there is severe malnutrition and poor oral hygiene. The infection probably involves several organisms, including spirochetes and fusiform bacilli. It is uncertain if it is transmitted by the exchange of saliva in kissing, but its epidemic increase in wartime and its frequency in the sexually promiscuous suggest this. Vincent disease is treated with antibiotics followed by trimming of the gum margins to eliminate subgingival pockets.

Oral cancer is sometimes caused by chronic thermal irritation in heavy smokers and is often preceded by leukoplakia (plaquelike patches arising on the mucous membranes of the cheeks, gum, or tongue). Similarly, oral cancer can be caused by the habit of keeping tobacco in the space between the cheek and the teeth. These cancers arise from the squamous cells that line the oral mucosa. Cancers of the salivary glands and of the mucous membranes of the cheeks cause pain, bleeding, or difficulty in swallowing. The lymphomas and other tumours of lymphoid origin may first appear in the tonsillar or pharyngeal lymph nodes. Cancer of the tongue and of the bony structures of the hard palate or sinuses may project into the mouth or may burrow deep into the surrounding tissues.

Dental caries: Dental caries, or cavities, are due to the destruction of the dental enamel and underlying tissues by organic acids. These acids are formed by bacteria growing in debris and food accumulated in pockets between the base of the teeth and the gum margins. Poor oral hygiene is the underlying predisposing circumstance. Malnutrition due to poverty, alcoholism, and malabsorption of vitamin D (rickets) or of proteins (as in celiac disease), initiate or aggravate caries. This periodontal infection ultimately leads to the invasion of the dental pulp, and the involvement of the nerve in the inflammation is the cause of toothache. An abscess may form at the apex of the tooth and extend into the jawbone, causing osteomyelitis (inflammation of the bone), or into the soft tissues around the roots of the teeth, causing cellulitis (inflammation of the soft tissues). Halitosis (foul breath) is due to the rotting debris in the pockets under the gum margins. Eventually the teeth loosen and fall out or need to be extracted. The resistance of the dental enamel to damage by organic acids is increased by fluoride, and in many countries this is incorporated into toothpaste formulas and is added to the water supplied to homes. In areas where these steps have been taken, the incidence of caries has dropped by more than 50 percent.

Pharyngitis: Inflammation of the posterior wall of the mouth and of the tonsils and adjoining tissue on each side of the oral pharynx is very common, especially in young persons. Such infections are due to bacteria of the streptococcal and staphylococcal species or from viral infections. In viral pharyngitis the tissue is usually less red and swollen than is true of streptococcal pharyngitis, and it is less often covered by a whitish exudate (protein-rich fluid). Other tonsillar tissue in the upper part of the pharynx and at the root of the tongue may be similarly involved. In diphtheritic pharyngitis, the membranous exudate is more diffuse than in other types of pharyngitis, it is tougher, and it extends over a much larger part of the mucous membrane of the mouth and nose. One of the complications of tonsillitis or pharyngitis may be a peritonsillar abscess, also called quinsy, adjacent to one tonsil; this appears as an extremely painful bulging of the mucosa in the area. Surgical incision and draining are sometimes necessary if antibiotics are not given promptly.

Congenital defects: Cleft lip, also known as harelip, is a congenital deformity in which the central to medial lip fails to fuse properly, resulting in a fissure in the lip beneath the nostrils. Other disorders are related to an abnormal position of the teeth and the jaws, resulting in inefficient chewing, and to the absence of one or more of the salivary glands, which may lessen the amount and quality of saliva that they produce. Neurological defects that provide inadequate stimulation to the muscles of the tongue and the pharynx can seriously impair chewing and even swallowing. Sensory-innervation defects may not allow the usual reflexes to mesh smoothly, or they may permit harmful ingestants to pass by undetected.

2.SALIVARY GLANDS

The secretion of saliva is markedly diminished in states of anxiety and depression. The consequent dry mouth interferes with speech, which becomes thick and indistinct. In the absence of the cleansing action of saliva, food debris persists in the mouth and stagnates, especially around the base of the teeth. The debris is colonized by bacteria and causes foul breath (halitosis). In the absence of saliva, swallowing is impeded by the lack of lubrication for the chewing of food that is necessary to form a bolus. The condition is aggravated in states of anxiety and depression when drugs that have an anticholinergic-like activity (such as amitriptyline) are prescribed, because they further depress the production of saliva. The salivary glands are severely damaged and atrophy in a number of autoimmune disorders such as Sjögren disease and systemic lupus erythematosus. The damage occurs partly by the formation of immune complexes (antigen-antibody associations), which are precipitated in the gland and initiate the destruction. In these circumstances, the loss of saliva is permanent. Some symptomatic relief is obtained by the use of “artificial saliva,” methylcellulose mouthwashes containing herbal oils such as peppermint. As some of the salivary glands retain their function, they may be stimulated by chewing gum and by a parasympathomimetic agent such as bethanecol. The production of saliva may be also impaired by infiltration of the salivary glands by pathological lymphocytes, such as in leukemias and lymphomas. In the early stages of these diseases, the glands swell and become painful.

Excessive production of saliva may be apparent in conditions interfering with swallowing, as in Parkinson disease, or in pseudobulbar paralysis from blockage of small arteries to the midbrain regions. True salivary hypersecretion is seen in poisoning due to lead or mercury used in certain industrial processes and as a secondary response to painful conditions in the mouth, such as aphthous stomatitis (certain ulcers of the oral mucosa) and advanced dental caries.

Acute and painful swelling of salivary glands develops when salivary secretion is stimulated by the sight, smell, and taste of food but saliva is prohibited from flowing through an obstructed salivary duct. Swelling and pain subside between meals. Diagnosis can be confirmed by X ray. Persistent swellings may be due to infiltration by benign or malignant tumours or to infiltration by abnormal white blood cells, as in leukemia. The most common cause of acute salivary swelling is mumps.

3. ESOPHAGUS

Difficulty in swallowing (dysphagia) may be the only symptom of a disorder of the esophagus. Sometimes dysphagia is accompanied by pain (odynophagia), or pain may occur spontaneously without swallowing being involved. The esophagus does nothing to alter the physical or chemical composition of the material it receives, and it is poorly equipped to reject materials that have got past the intricate sensors of the mouth and throat. Consequently, it is vulnerable to mucosal injury from ingestants as well as to materials that reflux into its lower segment from the stomach. Although the esophageal muscle coats are thick, the esophagus is not protected with a covering of serous membrane, as are neighbouring organs in the chest.

Congenital defects: Congenital defects of the esophagus are most often seen in infancy, primarily as a failure to develop normal passageways. Infants born with openings between the esophagus and trachea cannot survive without early surgery. The lower end of the esophagus is subject to various developmental abnormalities that shorten the organ so that the stomach is pulled up into the thoracic cavity. Abnormalities of the diaphragm may contribute to a similiar outcome.

Inflammatory disorders: Inflammatory disorders of the esophagus result from a variety of causes, from the ingestion of noxious materials, the lodgment of foreign bodies, to a complex of events associated with reflux of gastric contents from the stomach into the lower esophagus. Inflammation resulting from surface injury by caustic substances is called corrosive esophagitis. When the problem is associated with reflux, the term peptic esophagitis is applied to inflammation involving both the mucous membrane and the submucosal layer. A number of other diseases may cause inflammation of the esophagus, e.g., scleroderma, a disease in which the smooth muscle of the organ degenerates and is eventually replaced by fibrous tissue, and generalized candidiasis, a disease in which the esophagus is often involved in a septic process characterized by many small abscesses and ulcerations.

Strictures: Fibrous (scar) tissue contracts over time. Consequently, when fibrous tissue develops around a tube, as in the esophagus, in response to inflammation, the contracting scar narrows the lumen, causing a stricture, and may eventually obstruct it completely. Strictures are readily diagnosed by X ray or esophagoscope.

Dysphagia: Dysphagia is characterized by difficulty in swallowing caused by lesions, failure to transport a bolus through the esophagus, or mechanical obstruction by stricture, tumours, or foreign bodies in the esophagus. In persons over 50 years of age, the sensation of food “sticking” is more often caused by a disease process, frequently a tumour, involving the wall of the esophagus and providing a mechanical rather than a functional obstacle to the passage of food. The neural arc of swallowing involves the medulla of the brain stem, the vagus (10th cranial) nerves, and the glossopharyngeal, trigeminal, and facial nerves. Consequently, dysphagia may also result from interference with the function of any part of this pathway. Thus, it occurs commonly, but usually transiently, in strokes. Dysphagia may be prominent in degenerative diseases of the central nervous system, especially of the ganglia at the base of the brain. In these circumstances, the behaviour of the smooth muscle of the pharynx and the upper esophageal sphincter is disturbed.

Most individuals can locate the site of dysphagia and the distribution of the pain with accuracy. A sense of food sticking or of pain on swallowing, however, may be felt to be in the throat or upper sternum when the obstruction or disease is in fact at the lower end of the esophagus. The sensation of a “lump in the throat,” or “globus hystericus,” is not connected with eating or swallowing. The sensation may result from gastroesophageal reflux or from drying of the throat associated with anxiety or grief. Treatment is directed toward the cause of the disorder.

Pain: The nerves conveying the sense of pain from the esophagus pass through the sympathetic system in the same spinal cord segments as those that convey pain sensations from the muscle and tissue coverings of the heart. As a result, episodes of pain arising from the esophagus as a result of muscle spasm or transient obstruction by a medicine tablet or other object may be experienced in the chest and posterior thorax and radiate to the arms. This pain thus mimics pain of cardiac origin (angina). The pain due to transient obstruction may be felt not only in the chest but also, through radiation to the back, between the shoulder blades. It is very similar to pain from gallstones; attacks last 10 to 30 minutes.

In middle-aged and elderly persons, spontaneous and diffuse spasm of the smooth muscle of the esophagus causes considerable discomfort as well as episodes of dysphagia. Alternative names for the condition are “corkscrew” esophagus and diffuse spasm of the esophagus. The appearance of the esophagus seen on an X-ray screen while a barium bolus is swallowed resembles that of the outline of a corkscrew because of the multiple synchronized contractions at different levels of the spirally arranged smooth muscle. The pain of esophageal spasm may be relieved by medications that relieve cardiac angina, especially nitroglycerin or nifedipine.

Motility: Disorders of the motility of the esophagus tend to be either caused by or aggravated during times of stress. Eating rapidly is another trigger, as this demands more precise and rapid changes in muscle activity than eating slowly. Achalasia, formerly called cardiospasm, is a primary disturbance in the peristaltic action of the esophagus that results in failure to empty the organ of its contents. The lower sphincteric portion of the esophagus does not receive its normal signal to relax and, over time, may become hypertonic, resisting stretching. A cycle occurs in which the main portion of the esophagus slowly becomes distended, holding a column of fluid and food that it cannot propel downward to a lower esophageal sphincter that stays closed because of a failure in its neural system. In most persons with this disorder, there is a shortage or disease of ganglion cells of the myenteric plexus (Auerbach plexus), or a disease of the network of nerves within the muscles of the esophagus, so that coordinated peristalsis becomes impossible. In Chagas disease, parasites called trypanosomes invade the neural tissue and directly destroy ganglion cells. These organisms are not present in the temperate zones of the world, however, and the reason for ganglion cell degeneration in achalasia is generally unknown. Effective treatment is achieved by destroying the ability of the lower esophageal sphincter of the esophagus to contract. This may be done by forcible dilatation, using a balloon, of the esophagus in the area that is tonically contracted. The objective is to rupture the circular muscle at the site, and this is generally achieved with one or two dilatations. If this fails to overcome the contraction or if the contraction recurs, surgery is required that involves opening the abdomen and cutting through the circular muscles from the outside of the esophagus. The disadvantage of both methods of treatment is that the anti-reflux mechanism is thereby destroyed. Consequently, if precautions are not taken, the individual may lose the symptoms and risks of achalasia but may develop the symptoms and signs of reflux peptic esophagitis.

Gastroesophageal reflux: In healthy individuals, reflux of gastric contents into the esophagus occurs occasionally. This causes the burning sensation behind the sternum that is known as heartburn. Some of the refluxed material may reach the pharynx where it also may be felt as a burning sensation. Reflux is most likely to occur after large meals, especially if physical activity, including bending, stooping, or lifting, is involved. In these circumstances, the esophagus responds with peristaltic waves that sweep the gastric contents back into the stomach, with relief of the heartburn.

Persistent reflux symptoms are invariably due to inadequate functioning of the anatomical components, such as the lower esophageal sphincter, which keep the contents of the stomach below the diaphragm, delayed esophageal clearance of the refluxed material, and delayed emptying of the stomach. The disorder can also be caused by obesity. Excessive fat on the trunk is almost always accompanied by large deposits of fat within the abdomen, especially in the mesentery (the curtainlike structure on which most of the intestine is hung). Consequently, when intra-abdominal pressure is increased, such as in physical activity, there is insufficient room within the abdomen to accommodate the displacement of the organs, and the resulting pressure forces the stomach upward. The weak point is the centre of the diaphragm at the opening (hiatus) through which the esophagus passes to join the stomach. The upper portion of the stomach is pushed through the hiatus, and the distortion of the position of the organs brings about impaired functioning of the anti-reflux mechanisms. In the early stages the stomach may slide back into the abdomen when the increase in the intra-abdominal pressure eases, but eventually, if the circumstances are unchanged, the upper part remains above the diaphragm. A common contributory cause of gastroesophageal reflux in women is pregnancy. As the uterus containing the developing fetus comes to occupy a large part of the abdomen, the effect is the same as in obesity. Because gravity is the only force that keeps the gastric contents within the stomach, if a hernia develops, the reflux and the symptoms from it will promptly occur when the individual lies down. Persisting reflux of gastric contents with acid and digesting enzymes leads to chemical inflammation of the lining of the esophagus and ultimately to peptic ulceration. If inadequately treated, the process leads to submucosal fibrosis and stricturing, and, besides the symptoms of heartburn and regurgitation, the patient experiences pain on eating and swallowing.

The treatment of peptic reflux esophagitis includes losing weight, avoiding acidic and fatty foods and beverages, remaining upright for two to three hours after meals, giving up smoking, and raising the head of the bed high enough to discourage nocturnal gastroesophageal reflux. Antacids are effective, as are medications that reduce the secretion of acid by the stomach, such as histamine receptor antagonists and proton pump inhibitors. If a stricture has formed, it can be dilated easily. If the disorder is not overcome with these conservative measures, surgical repair is performed through either the chest or the abdomen.

Some individuals with severe peptic reflux esophagitis develop Barrett esophagus, a condition in which the damaged lining of the esophagus is relined with columnar cells. These cells are similar to those lining the upper part of the stomach and are not the usual squamous cells that line the esophageal mucosa. In some persons in whom this transformation occurs, a carcinoma develops some 10 to 20 years later. The decision as to the treatment of a hiatal hernia by conservative means or by surgery is influenced by such factors as age, occupation, and the likelihood of compliance with a strict regimen.

There is a much less common form of hiatal hernia, called a paraesophageal hernia, in which the greater curvature of the stomach is pushed up into the thorax while the esophagogastric junction remains intact below the diaphragm. Such individuals experience dysphagia caused by compression of the lower esophagus by the part of the stomach that has rolled up against it. This rarer form of hernia is more dangerous, often being complicated by hemorrhage or ulceration, and requires relief by surgery.

Diverticula: Pouches in the walls of the structures in the digestive system that occur wherever weak spots exist between adjacent muscle layers are called diverticula. In the upper esophagus, diverticula may occur in the area where the striated constrictor muscles of the pharynx merge with the smooth muscle of the esophagus just below the larynx. Some males over 50 years of age show protrusion of a small sac of pharyngeal mucous membrane through the space between these muscles. As aging continues, or if there is motor disturbance in the area, this sac may become distended and may fill with food or saliva. It usually projects to the left of the midline, and its presence may become known by the bubbling and crunching sounds produced during eating. Often the patient can feel it in the left side of the neck as a lump, which can be reduced by pressure of the finger. Sometimes the sac may get so large that it compresses the esophagus adjacent to it, producing a true obstruction. Treatment is by surgery. Small diverticula just above the diaphragm sometimes are found after the introduction of surgical instruments into the esophagus.

Boerhaave syndrome is a rare spontaneous rupture to the esophagus. It can occur in patients who have been vomiting or retching and in debilitated elderly persons with chronic lung disease. Emergency surgical repair of the perforation is required. A rupture of this type confined to the mucosa only at the junction of the linings of the esophagus and stomach is called a Mallory-Weiss lesion. At this site, the mucosa is firmly tethered to the underlying structures and, when repeated retching occurs, this part of the lining is unable to slide and suffers a tear. The tear leads to immediate pain beneath the lower end of the sternum and bleeding that is often severe enough to require a transfusion. The circumstances preceding the event are commonly the consumption of a large quantity of alcohol followed by eating and then vomiting. The largest group of individuals affected are alcoholic men. Diagnosis is determined with an endoscope. Most tears spontaneously stop bleeding and heal over the course of some days without treatment. If transfusion does not correct blood loss, surgical suture of the tear may be necessary. An alternative to surgery is the use of the drug vasopressin, which shuts down the blood vessels that supply the mucosa in the region of the tear.

Cancer of esophagus: Esophageal tumours may be benign or malignant. Generally, benign tumours originate in the submucosal tissues and principally are leiomyomas (tumours composed of smooth muscle tissue) or lipomas (tumours composed of adipose, or fat, tissues). Malignant tumours are either epidermal cancers, made up of unorganized aggregates of cells, or adenocarcinomas, in which there are glandlike formations. Cancers arising from squamous tissues are found at all levels of the esophagus, whereas adenocarcinomas are more common at the lower end where a number of glands of gastric origin are normally present. Tumours produce difficulty in swallowing, particularly of solid foods; they are much more common in men than in women, and they seem to vary greatly in their worldwide distribution. In North China, for example, the incidence of esophageal cancer in men is 30 times that of white men in the United States and 8 times that of black men. The exact causes of esophageal cancer are not known. Risk factors may include age, sex, smoking, excessive consumption of alcohol, Barrett esophagus, and a personal history of cancer.

In women, cancer of the upper esophagus is more common than in men, and women may be predisposed by long-standing iron deficiency, or Plummer-Vinson (Paterson-Kelly) syndrome. Dysphagia is the first and most prominent symptom. Later swallowing becomes painful as surrounding structures are involved. Hoarseness indicates that the nerve to the larynx is affected. The diagnosis is suggested by X ray and proved by endoscopy with multiple biopsies from the area of abnormality. Diagnosis can be reinforced by removing quantities of cells with a nylon brush for examination under a microscope (exfoliative cytology). The prognosis is poor because the tumour has usually been growing for one or two years before symptoms are apparent. The channel of the esophagus is encroached upon and can be almost entirely obstructed. Esophageal cancer is usually accompanied by considerable weight loss, but nutrition may be restored by nutritional supplements. In advanced cases, a tube may be inserted into the esophagus to keep it open. Where the channel is greatly narrowed, the size of the tumour can be reduced by destroying the tissue with lasers. Radiotherapy is used for malignancies of the upper esophagus and as treatment for those at the lower end. A combination of radiotherapy followed by surgical excision may also be used. The five-year survival rate for esophageal cancer remains very low. Lessening the effects of the disease, with restoration of eating ability, is very important, because otherwise the inability to swallow even saliva is distressing and starvation may result.

4. STOMACH

Indigestion: Indigestion, also called dyspepsia, is any or all of the unpleasant symptoms that are associated with the malfunctioning of the digestive system. Indigestion may be caused by a disease, but it primarily occurs because of stress or improper eating habits, smoking, drinking excessive quantities of coffee or alcohol, or hypersensitivity to particular foods. Any disorder that affects the coordination of the stomach muscles is capable of producing symptoms ranging from those that are mildly unpleasant to others that are life-threatening. Symptoms include abdominal discomfort, belching, flatulence, anorexia, nausea, vomiting, diarrhea, constipation, and heartburn. Anorexia and nausea seem to be mediated through the central nervous system, with reflex input from nerve endings in the stomach and duodenum. Sometimes the entire duration of a nausea-vomiting episode is so short that it appears to be vomiting alone, obscuring the presence of nausea. This is characteristically noted in persons with primary diseases of the brain, especially those with tumours or meningitis in which the cerebrospinal fluid is under increased pressure. In many diseases, vomiting may not be preceded by nausea at all, and in others there may be a long time lag between the two. Seasickness is the best-known example of this relationship.

The intrinsic muscles of the stomach are innervated by branches of the vagus nerves, which travel along the esophagus from their point of emergence in the brain stem. Gastric retention may result from the degeneration of these nerves that can result from diabetes mellitus. Obstruction due to scarring in the area of the gastric outlet, or to tumours encroaching on the lumen, causes the stomach to fill up with its own secretions as well as with partially digested food. In these circumstances, vomiting leads to dehydration and to electrolyte losses, which threaten life if not corrected. The ingestion of soluble alkali in this situation may aggravate the disturbance in the acid-base balance of the body. Bulimia, a nervous disorder characterized by compulsive eating followed by vomiting and purging, can cause severe dehydration and even a ruptured stomach, and it can prove fatal.

Ulcerative diseases: Ulcers are produced when external factors reduce the ability of the mucosal lining to resist the acidic effects of gastric juice (a mixture of digestive enzymes and hydrochloric acid). The area of the stomach in which acid and pepsin are secreted has the highest resistance to peptic ulcer. The mucosa elsewhere is less well protected, and its breakdown may lead to ulceration. If the lesion is confined to the superficial layers of the mucosa, it is called an erosion; if it extends through the intrinsic layer of muscle of the mucosa into the tissues below, it is known as an ulcer. Erosions and ulcers can be acute or chronic according to how readily they heal. Infection with the bacterium Helicobacter pylori and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) are the two major causes of ulcers. In special circumstances such as the state of shock produced by large burns, intracranial surgery, coronary occlusion, and septicemia, acute and rapidly penetrating ulcers may occur.

In the Western world duodenal ulcer is much more common than gastric ulcer, occurs more often in men than in women, and is aggravated by stress. In Japan gastric ulcer is more common than duodenal ulcer and is thought to be related to the raw fish and acetic acid pickles of the traditional diet. Duodenal ulcer is most common between 25 and 35 years of age, while gastric ulcer is uncommon before 40 years and has a peak frequency between 55 and 65 years. Genetic factors are also involved in the development of ulcers. Inheriting blood group O may render a person more likely to develop duodenal ulceration. There are families in whom the secretion of pepsinogen I is excessive and renders them prone to duodenal ulcer since excess acid secretion is linked to excess secretion of this hormone.

Pain is the major symptom of duodenal ulcers. The pain is a burning or gnawing sensation felt in the midupper abdomen. In gastric ulcer it comes on soon after eating, whereas in duodenal ulcer it comes on when the stomach is empty, one and a half to two hours after meals and during the night hours. In the early stages of the disease, the pain is easily and immediately relieved by antacids and, in duodenal ulcer, by light food.

Gastric ulcers almost always recur in the same site within the stomach, but duodenal ulcers are often multiple, and recurrence may be anywhere in the duodenal bulb. Furthermore, duodenal ulcers are usually accompanied by an inflammation affecting the whole bulb (duodenitis). Multiple erosions varying in size between 0.5 and 5 millimetres are frequently scattered over the mucosa. With gastric ulcers the inflammation is usually confined to the immediate vicinity of the crater and, as a rule, is not accompanied by erosions. The exceptions are gastric ulcers in the antrum and prepyloric area associated with the use and abuse of analgesics and NSAIDs for arthritic disorders, in which multiple erosions are commonly present.

The most common site of gastric ulcers is halfway up the inner curvature of the stomach at the junction of the lower one-third with the upper two-thirds of the organ. This may be because blood flow to this site is more easily reduced than elsewhere. Chronic gastric ulcers at this site are strongly associated with obstructive disease of the airways (chronic bronchitis and emphysema). Smoking impairs the healing of both gastric and duodenal ulcers.

Infection with H. pylori is the most common bacterial infection in humans; it is pervasive in the Third World, and in the United States it affects about a third of the population. Among those who suffer from peptic ulcers, as many as 90 percent of those with duodenal ulcers and 70 percent with gastric ulcers are believed to be infected with H. pylori. This bacterium converts the abundant waste product urea into carbon dioxide and ammonia. The process causes the mucosal lining to break down. In its weakened condition the lining cannot withstand the corrosive effects of gastric acid, and an ulcer can form.

The complications of peptic ulcers are hemorrhage, perforation, and obstruction of the outlet of the stomach (pyloric stenosis) by scarring of the duodenal bulb or of the pyloric channel. Scarring often leads to bouts of vomiting and accompanying malnutrition and requires surgery. Bleeding may be obscured because of oozing from the floor of the ulcer and detectable only by laboratory testing of the feces, or bleeding may be brisk, leading to the passage of tar-coloured stools (melena). Occasionally, when the ulcer erodes into a large vessel, bleeding is excessive and life-threatening. The mortality associated with bleeding is high in the elderly because of chronic changes in the lungs, heart, and blood vessels, which reduces cardiorespiratory reserves. This is further aggravated by smoking. Brisk bleeding is usually accompanied by the vomiting of blood (hematemesis), which requires treatment by blood transfusion. In the elderly, hardening of the arteries (atherosclerosis) prevents the vessel from closing down around the lesion. If bleeding persists or recurs, surgery is necessary. Ulcers that penetrate the back wall of the stomach or duodenum erode into the pancreas, and back pain becomes prominent. If the ulcer penetrates the anterior wall, free perforation into the abdominal cavity may occur. This causes immediate, intense pain and shock, and the abdominal wall becomes rigid. In most instances this requires emergency surgery with drainage of the abdomen.

Surgery for chronic ulceration is used less frequently since the introduction of drugs that stop the secretion of stomach acid. Histamine-receptor antagonists, such as cimetidine, ranitidine, and famotidine, block the action of histamine on the acid-secreting parietal cells of the stomach. Proton pump inhibitors, such as omeprazole, lansoprazole, and rabeprozale, inhibit the ATPase enzyme inside the parietal cell and prevent acid secretion. Most peptic ulcers not caused by H. pylori infection result from the ingestion of large quantities of NSAIDs. Withdrawal of NSAID treatment usually allows the ulcer to heal. Treatment for H. pylori–induced ulcers are antibiotics and a proton pump inhibitor.

Gastritis: A diffuse inflammation of the stomach lining, gastritis is usually an acute disorder caused by contaminated food, by alcohol abuse, or by bacterial- or viral-induced inflammation of the gastrointestinal tract (gastroenteritis). Such episodes are short-lived and require no specific treatment. Pain is generalized in the upper abdomen and is continuous, but it progressively subsides over two or three days. Aspirin and NSAIDs taken for arthritis cause erosions in the antrum of the stomach and in some instances cause bleeding and chronic ulceration. Infection by the bacteria H. pylori is also a common cause of chronic gastritis. This usually responds to the withdrawal of the offending drugs and treatment with the same agents used to treat peptic ulcers of the stomach and duodenum.

Another form of gastritis is gastric atrophy, in which the thickness of the mucosa is diminished. Gastric atrophy is often the culmination of damage to the stomach over many years. Diffuse gastric atrophy leads to partial loss of the glandular and secreting cells throughout the stomach and may be associated with iron deficiency anemia. Atrophy of the mucosa confined to the body and fundic regions of the stomach is seen in pernicious anemia and is due to the formation of antibodies to intrinsic factor secreted by the parietal cells. Intrinsic factor is necessary to the absorption of vitamin B12.

Cancer of stomach: Malignant tumours of the stomach are common, but the incidence of stomach cancer varies from country to country, probably a result of both genetic and environmental factors. Stomach cancer often occurs in older persons whose stomachs produce only small quantities of acid. Infection with H. pylori–associated chronic gastritis may be a risk factor in developing stomach cancer. Stomach cancer affects men more often than women and accounts for about 10 percent of all deaths from cancers of the gastrointestinal tract in the United States. In Japan, on the other hand, it accounts for nearly 80 percent of such cancers in males, possibly due to diet.

Other malignant tumours that involve the stomach are ordinarily made up of lymphoid and connective tissue. Benign tumours, especially leiomyomas, are common and may, when large, cause massive hemorrhage. Polyps of the stomach are not common except in the presence of gastric atrophy. Treatment for these tumours, benign or malignant, is surgery.

Because symptoms produced by tumours of the stomach are highly variable, there are no common characteristics of the disease in its early stages. The symptoms most often seen are loss of appetite, some weight loss, and symptoms attributable to anemia, a condition that frequently is present because of blood loss into the stools, which, though constant, is usually so minimal as to escape notice by the patient. Tumours in the lower part of the stomach produce obstructive symptoms, and tumours high in the stomach may obstruct the esophageal entry into the stomach, producing difficulty in swallowing. Although pain is usually mild, it may be the most noticeable symptom. Stomach cancers often spread to neighbouring lymph nodes or to the liver.

5.DUODENUM

The duodenum is often involved in the diseases of its neighbours, in particular the pancreas and the biliary tract. Primary cancer of the duodenum is an infrequent disease. Benign tumours, particularly polyps and carcinoids, are more frequent. Cancers of the common bile duct or of the pancreas may make their presence known by obstruction of the duodenum and pain. These cancers often are diagnosed by upper intestinal X-ray studies, endoscopy, ultrasound, or computed tomography (CT) scanning. Benign anomalies of the organs of this area, like an encircling ring of pancreas, may also encroach upon the duodenum. In countries of the Middle and Far East, where parasites are endemic, roundworms and tapeworms in particular are often found anchored in the duodenum. In inflammations of the pancreas, the motility of the neighbouring duodenum is often impaired, and occasionally ulceration with hemorrhage occurs. A protozoal parasite, Giardia lamblia, can contaminate drinking water and is a common cause of diarrhea and, if unrecognized, malabsorption.

6.SMALL INTESTINE

A lack of coordination of the inner circular and outer longitudinal muscular layers of the intestinal wall usually results in an accumulation of excess contents in the intestinal lumen, with consequent distension. This distension may cause pain and usually results in hyperactive contractions of the normal segment next to the distended area. Such contractions may be strenuous enough to produce severe, cramping pain. The most common cause of disturbed motility in the small intestine is food that contains an unsuitable additive, organism, or component.

Traveler's diarrhea: Traveler's diarrhea is the abnormally swift passage of watery waste material through the large intestine, with consequent discharge of loose feces. Traveler's diarrhea is accompanied by cramping and lasts a few days. It is almost always caused by toxin-generating Escherichia coli. Shigella infection may occur simultaneously, however, and visitors to countries where giardiasis is endemic may suffer infection. Contaminated salads remain the most common cause of traveler's diarrhea in countries where the climate is hot. Such diarrhea generally disappears spontaneously with abstention from food accompanied by drinking of nonalcoholic fluids. Mixtures of sodium and potassium chloride, sodium bicarbonate, and glucose reconstituted with water are one method of treatment.

Intestinal obstruction: The common disorder known as irritable bowel syndrome (IBS) is probably due to a disturbance of the motility of the whole intestinal tract or to increased sensitivity of the large intestine. The symptoms vary from watery diarrhea to constipation and the passage of stools with difficulty. When the colon is involved, an excess of mucus is often observed in the stools. Pain and cramping are most often felt in the lower abdomen. Generalized abdominal discomfort, sometimes with nausea, may follow defecation and may last 15 to 30 minutes. Many sufferers experience high levels of stress, and some have periods of anxiety depression.

Occasionally irritable bowel syndrome may be due to an allergy to specific foods. IBS may develop following an infection such as bacillary dysentery, after which the small intestine remains irritable for many months. Treatment of IBS includes elimination of stress, psychological support, change in lifestyle, and exercise. Possible aggravating items such as lactose-containing foods, coffee, and deep-fried dishes should be eliminated from the diet, and dietary fibre should be added to help in resolving constipation. When discomfort is prominent, antispasmodic agents that relax smooth muscle, such as dicyclomine hydrochloride or mebeverine, may be prescribed. If diarrhea does not respond to dietary measures, diphenoxylate or loperamide may slow the movement of the intestinal contents, thereby increasing the potential for the reabsorption of water.

Malabsorption: Malabsorption occurs when the small intestine is unable to transport broken-down products of digestive materials from the lumen of the intestine into the lymphatics or mesenteric veins, where they are distributed to the rest of the body. Defects in transport occur either because the absorptive cells of the intestine lack certain enzymes, whether by congenital defect or by acquired disease, or because the cells are hindered in their work by other disease processes that infiltrate the tissues, disturb motility, permit bacteria to overpopulate the bowel, or block the pathways over which transport normally proceeds. Malabsorption also may result from pancreatitis, cystic fibrosis, obstruction of the bile ducts or lymphatic vessels, or surgical removal of a section of the small intestine.

Diagnosis of malabsorption is determined primarily from the patient's history, physical examination, X-ray films of the abdomen, and study of the stools under controlled dietary conditions. Motor aspects of the intestine can be studied using a variety of techniques. A biopsy of the small intestine may also be performed to detect abnormalities.

Congenital malformations: Meckel diverticulum is a common congenital malformation that occurs when the duct leading from the navel to the small intestine in the fetus fails to atrophy and close. The duct serves as the principal channel for nourishment from the mother. The diverticulum in the child or adult may range from a small opening to a tube that is a foot or more in length; it may contain cells derived from the stomach glands that secrete acid and pepsin. If such secretions spill onto intestinal mucosa, the mucosa ulcerates and often bleeds. Thus a peptic ulcer can develop at a site far from the stomach or duodenum. The peptic ulcer gives rise to pain, bleeding, or obstruction, and it is the most common cause of bleeding from the lower intestine in children. Meckel diverticulum must be treated surgically if complications develop.

Another congenital problem in the small intestine is the presence of multiple diverticula, or outpouchings of mucosa and serosa. Multiple diverticula are seen usually in elderly persons, although occasionally one may be the site of acute inflammation in a young adult. Bacteria flourish in these diverticula because the outpouchings have no motor activity and cannot empty themselves. The bacteria deprive the body of nutrients and may cause diarrhea and serious malabsorption. The overgrowth of bacteria also upsets the motor activity of the small intestine. Antibiotics may control the condition in the elderly, but surgical resection of diverticula is necessary in younger persons.

Bacterial infections: Many bacterial organisms can infest the human body and cause disease. Species of Salmonella that cause typhoid and paratyphoid remain endemic scourges in tropical countries and, together with Shigella, are occasional causes of epidemics in institutions, especially among the elderly. Diagnosis is confirmed by the presence of the organisms in a stool culture. Antibiotics and solutions rich in electrolytes are effective therapy. Treatment is with antibiotics. Periodic vaccination is advisable for the protection of individuals exposed to areas where typhoid and paratyphoid are endemic.

Cholera, caused by Vibrio cholerae, is endemic to Southeast Asia and periodically becomes pandemic (widely distributed in more than one country). The oral or intravenous administration of electrolyte solutions rich in potassium has revolutionized the treatment of cholera, because deaths are due to a massive depletion of electrolytes and water. The toxin produced by V. cholerae attaches to the intestinal cells, the enterocytes, where it stimulates the membrane enzyme adenylate cyclase; this in turn interferes with the intracellular enzyme 3′,5′-cyclic adenosine monophosphate synthetase (cyclic AMP), thereby disrupting the sodium pump system for movement of water and allowing potassium and bicarbonate to seep out of the cell.

Typhoid is a acute infectious disease caused by a specific serotype of the bacterium Salmonella typhi. The bacterium usually enters the body through the mouth by the ingestion of contaminated food or water, penetrates the intestinal wall, and multiplies in lymphoid tissue; it first enters into the bloodstream within 24 to 72 hours, causing septicemia (blood poisoning) and systemic infection.

After an average 10–14-day incubation period, the early symptoms of typhoid appear: headache, malaise, generalized aching, fever, and restlessness that may interfere with sleep. There may be loss of appetite, nosebleeds, cough, and diarrhea or constipation. Persistent fever develops and gradually rises, usually in a stepwise fashion, reaching a peak of 39 or 40 °C (103 or 104 °F) after 7–10 days and continuing with only slight morning remissions for another 10–14 days.

During about the second week of fever, when typhoid bacilli are present in great numbers in the bloodstream, a rash of small, rose-coloured spots appears on the trunk, lasts four or five days, and then fades away. The lymph follicles (Peyer patches) along the intestinal wall in which the typhoid bacilli have multiplied become inflamed and necrotic and may slough off, leaving ulcers in the walls of the intestine. The dead fragments of intestinal tissue may erode blood vessels, causing hemorrhage, or they may perforate the intestinal wall, allowing the intestine's contents to enter the peritoneal cavity (peritonitis). Other complications can include acute inflammation of the gallbladder, heart failure, pneumonia, osteomyelitis, encephalitis, and meningitis. With a continued high fever the symptoms usually increase in intensity, and mental confusion and delirium may appear.

By the end of the third week the patient is emaciated, abdominal symptoms are marked, and mental disturbance is prominent. In favourable cases, during about the beginning of the fourth week, the fever begins to decline, the symptoms begin to abate, and the temperature gradually returns to normal. If untreated, typhoid fever proves fatal in up to 25 percent of all cases. Patients with such diseases as cancer or sickle cell anemia are particularly prone to develop serious and prolonged infection with Salmonella.

Most major epidemics of typhoid fever have been caused by the pollution of public water supplies. Food and milk may be contaminated, however, by a carrier of the disease who is employed in handling and processing them; by flies; or by the use of polluted water for cleaning purposes. Shellfish, particularly oysters, grown in polluted water and fresh vegetables grown on soil fertilized or contaminated by untreated sewage are possible causes. The prevention of typhoid fever depends mainly on proper sewage treatment, filtration and chlorination of water, and the exclusion of carriers from employment in food industries and restaurants. In the early part of the 20th century, prophylactic vaccination using killed typhoid organisms was introduced, mainly in military forces and institutions, and contributed to a lowering of the incidence of the disease.

Diagnosis of typhoid fever is made by blood culture, stool culture, and serological testing. The treatment of typhoid fever is with antibiotics, particularly chloramphenicol. Chloramphenicol begins to lower the patient's fever within three or four days after beginning therapy, and there is progressive improvement thereafter. The drug treatment is continued for several weeks in order to prevent relapses.

Typhoid bacteria can persist in the bile passages of patients for an indefinite period of time. These carriers can pass the infection to healthy persons if they practice poor hygiene or if they are food handlers. About 30 percent of persons infected with typhoid fever become transient carriers of the disease, excreting the causative bacteria in the stool or urine for weeks or months. About 5 percent remain long-term carriers, harbouring the microorganisms and shedding them for years.

Parasitic infections: In tropical countries, parasitism is endemic. Roundworms, tapeworms, amoebae, hookworms, strongyloides, threadworms, and blood flukes (schistosomiasis) are the main types of parasites. Consequently it is commonplace in these areas for multiple parasite infestation to occur in addition to other disorders. This common occurrence, reflecting poverty, lack of health education, malnutrition, contaminated drinking water, and inadequate sanitation, is a major factor in chronic illness and early death.






Roundworms, particularly Ascaris lumbricoides, may cause intestinal obstruction if present in sufficient numbers. As they mature from the larval state to the adult worm, roundworms migrate through the body, causing ascariasis, an infection characterized by fever, pneumonitis (lung inflammation), cholangitis (inflammation of the bile ducts), and pancreatitis. Roundworms interfere with the absorption of fat and protein in the intestine, causing diarrhea. They are eliminated with the administration of piperazine or other anthelmintics, but occasionally surgery is required for obstruction.






Hookworm, or Ancylostoma duodenale, infection begins when the worm is in the larval stage. It penetrates the skin, usually of the feet, migrates during its life cycle through the liver and the lungs, and attaches to the mucosa of the small intestine where it matures. Hookworms deplete the body of nutrients, and a major effect is severe chronic iron-deficiency anemia. This effect can be corrected with the oral administration of iron, and the number of worms can be controlled with tetrachloroethylene or other anthelmintics.





Pinworms, or Enterobius vermicularis, live mainly in the cecum. The adult female migrates at night to the anus and lays eggs on the perianal skin, which cause anal itching. Transmission of the pinworm occurs via a fecal-oral route, and it can affect an entire family. Pinworms can be eradicated with piperazine or vyprinium embonate.





The common tapeworms are Taenia saginata, found in beef, and T. solium, found in pork. Larvae of Echinococcus granulosus, mature worms of the genus Diphyllobothrium, and some dwarf tapeworms also cause disease. Fertilized ova are passed in feces and are ingested by an intermediary host animal, such as a cow. The embryos migrate to the bloodstream and on reaching muscle or viscera develop into larvae. When the flesh is consumed by humans, the larvae pass into the intestine, where they attach and mature into adult worms. Thus the most common source of infection is inadequately cooked meat. Tapeworms found in beef and pork only give rise to symptoms if their number and size cause intestinal obstruction. Diphyllobothrium latum, a fish tapeworm, may cause a severe anemia similar to pernicious anemia, because it consumes most of the vitamin B12 in the diet of the host.

Appendicitis: Appendicitis is an inflammation of the vermiform appendix that may be caused by infection or partial or total obstruction. The primary symptom of appendicitis is abdominal pain. Appendicitis principally occurs in those younger than 35 years of age. The disorder is easily diagnosed and is treated with surgery. Widespread use of antibiotics for upper-respiratory and other diseases may have lessened the incidence of acute appendicitis, so that more cases of late-developing appendiceal abscess are being reported. Parasitic worms also can contribute to its incidence. Appendicitis occasionally occurs in elderly people, and instances where an abscess forms and bursts require urgent surgery.

Chronic inflammations: Chronic inflammations of the small intestine include tuberculosis and regional enteritis (Crohn disease). These disturbances are difficult to diagnose in their early stages because their initial symptoms are often vague. General symptoms include low-grade fever, a tendency toward loose stools, weight loss, and episodes of cramping abdominal pain caused by obstruction of the lumen and interference with normal muscular activity by inflammation of the intestinal wall. Diagnosis is usually determined by X ray or colonoscopy. A biopsy may also be performed to examine the lining of the small intestine. Tuberculosis is treated with specific drug therapy. In Crohn disease anti-inflammatory and immunosuppressive drugs are helpful. Surgical excision of the diseased segments of intestine may be necessary.

The incidence of Crohn disease is rising. About 60 percent of persons with Crohn disease require surgery because of obstruction of the intestinal lumen and another 20 percent because of fistulation, or connection, between adjacent structures— for example, from the sigmoid colon to the bladder. A combination of repeated surgical excisions from the small intestine and disease of the intestinal wall can result in a severe malabsorptive state. This sometimes requires long-term intravenous nutrition.

Celiac disease: Celiac disease affects between one in 500 and one in 2,000 persons, depending on the region of the world. Celiac disease is caused by damage to the mucosa of the small intestine due to an immune reaction to gluten, a protein present in wheat, rye, barley, and some oats.

Studies of the immune function of those with celiac disease suggest that at least a major part of the process is a delayed hypersensitivity reaction and that the morphological changes of the small intestine mucosa are correlated with the presence of circulating antibodies to gluten. Damage to the small intestine results in progressive atrophy, if not complete disappearance, of the microvilli and villi that line the intestinal tract. This dramatically reduces the area available for absorption, and malabsorptive diarrhea results. Celiac disease usually occurs between 6 and 24 months of age, but the disorder may not manifest itself until middle age or, if mild, may be unnoticed until then. Iron and folic acid deficiency anemias, softening of the bones (osteomalacia), and general weakness may be accompanied by a variety of disorders attributable to the nonabsorption of vitamins. Untreated, it is a serious though rarely life-threatening disease after infancy. Diagnosis is established by blood tests and biopsy. Withdrawal from the diet of foods that contain gluten generally brings about dramatic improvement and disappearance of all symptoms.

Tropical sprue: A malabsorption disorder of unknown cause, tropical sprue affects residents and visitors of tropical countries. It is associated with partial atrophy of the mucosa of the small intestine. Its symptoms are diarrhea, anorexia, and fatigue. If the disease is prolonged, anemia caused by malabsorption of vitamin B12 develops. Steatorrhea (excess fat in stools) is common, and glucose absorption is impaired. Prolonged treatment with antibiotics, such as tetracycline, and the replacement of vitamins, especially B12 and folic acid, are successful.


7. LARGE INTESTINE

A wide variety of diseases and disorders occur in the large intestine. Abnormal rotation of the colon is fairly frequent and occasionally leads to disorders. Unusually long mesenteries (the supporting tissues of the large intestine) may permit recurrent twisting, cutting off the blood supply to the involved loop. The loop itself may be completely obstructed by rotation. Such complications are usually seen in elderly patients and particularly in those with a long history of constipation.

Constipation: Constipation is the delayed passage of waste through the lower portion of the large intestine, with the ultimate discharge of dry, hardened feces from the anus. Constipation may be caused by lack of regularity of one's eating habits and spasms or obstruction of the large intestine. Brain disease, metabolic failure, or drugs can dull the normal signals that give rise to the urge to defecate. Poor abdominal musculature or a poor pelvic floor, sometimes the result of surgery or childbirth, makes it difficult to mobilize effective pressures to bring about defecation. Temporary constipation most often occurs in conjunction with a change or interruption in one's usual activities, as in travel or a change in eating or sleeping habits.

Congenital megacolon: Aganglionic megacolon, or Hirschsprung disease, is a condition of unknown cause that is characterized by the absence of ganglion cells and normal nerve fibres from the distal (or lower) 3 to 40 cm (1 to 16 inches) of the large intestine. Neuromuscular transmission is absent from this segment, and peristalsis cannot occur. It is thus a functional obstruction. In 10 percent of cases a larger segment is involved and, on rare occasions, the whole colon. The area of normal intestine above the obstruction works harder to push on the fecal contents, and eventually the muscle of the normal segment thickens. The entire colon thus slowly becomes more and more distended and thick-walled. Diagnosis is made by the examination of the microscopic appearance of a deep biopsy of the lower rectum. Various surgical procedures are used to correct the condition.

Acquired megacolon: Acquired megacolon is commonly caused by a combination of faulty toilet training and emotional disorders during childhood, in which the child withholds defecation. The administration of increasing amounts of laxatives fails to solve the problem permanently, and over time the intrinsic innervation in the intestinal wall is damaged. A dilated rectum full of feces develops over the years. The impacted feces act as an obstruction, and further fecal material piles up behind, with voluminus dilatation of the whole colon in some cases. Evacuation of the contents of the bowel prior to surgery, if it is required, may require hospitalization for up to three months. Acquired megacolon is occasionally encountered in those with schizophrenia and severe depression. It may be related to neurological disorders such as paraplegia, to unrecognized rectal strictures, and to some metabolic disorders. Severe degrees of constipation, often running in families and leading to megacolon, occur, but the cause has not been discovered. Resection of the colon and uniting the ileum to the rectum is effective treatment.

Diarrhea: Diarrhea is the abnormally swift passage of waste material through the large intestine, with consequent discharge of loose feces from the anus. Because water is normally absorbed from the colonic content, principally in the ascending, or right, colon, diarrhea can be caused by any inflammatory, neoplastic, or vascular disturbance of that part of the colon. Diarrhea can also be caused by bacterial, viral, or parasitic infection. Most cases of diarrhea are not serious and do not require treatment.

Diarrhea is common in those who are deficient in lactase, the enzyme that splits lactose (milk sugar) into its component parts, glucose and galactose. Shortly after drinking milk, such persons usually have severe intestinal cramping, followed later by watery diarrhea. The lactose in the milk is not broken down, and it stays in the lumen of the small intestine, drawing water to it. The increased bulk of fluid and sugar distends the intestine, which then contracts actively. The rapid contractions drive the material along the intestine into the colon, which cannot absorb the water rapidly enough. The resultant watery, unformed stools are frequently acidic.

Intestinal gas: Intestinal gas consists principally of swallowed air and partly of by-products of digestion. When a person is in an upright position, gas diffuses to the uppermost portions of the colon. There it is compressed by the contraction of adjacent segments, giving rise to pain that is localized either near the liver and gallbladder or under the diaphragm and heart. This pain can be incorrectly thought to be associated with diseases of these organs, whereas it is actually caused by increased gas in the colon. Eating slower to reduce the amount of air ingested, decreasing the intake of carbonated beverages and whipped foods that contain air bubbles, and avoiding certain gas-producing foods, such as most beans, onions, sprouts, nuts, and raisins, usually help to reduce flatulence.

Diverticula: Diverticula are small pouches or sacs that form in the wall of the large intestine. Arteries penetrate the muscular walls of the colon from its outside covering, the serosa, and distribute themselves in the submucosa. With aging, and perhaps in persons predisposed to the disorder, the channels in which these arteries lie become larger. If the peristaltic activity of the colon maintains a high pressure within its lumen, as in persons straining to defecate, the mucous membrane of the colon may be driven slowly into these channels and eventually may follow the arteries back to their site of colonic entrance in the serosa. At this time, the outward-pushing mucosa becomes a budding sac, or diverticulum, on the antimesenteric border of the colon with a connection to the lumen. In the Western world, multiple colonic diverticula occur in as many as 30 percent of persons older than 50 years. Diverticula are particularly common in those whose diets are deficient in fibre. Hypertrophy (increase in size and mass) of the muscle fibre of the colon, especially in the sigmoid region, precedes or accompanies diverticulosis; this is especially apparent in the diverticulosis in middle-aged persons as opposed to that in the elderly.

The principal dangers of diverticulosis are hemorrhage and inflammation. Hemorrhage results from the action of hard stools against the small arteries of the colon that are exposed and unsupported because of diverticula. As the arteries age, they become less elastic, less able to contract after bleeding begins, and more susceptible to damage. Diverticulitis occurs when the narrow necks of the diverticula become plugged with debris or undigestible foodstuff and when bacteria, uninhibited by the usual motor activity that keeps the intestine clean, proliferate in the blind sacs. When the sacs enlarge, the adjacent intestinal wall becomes inflamed and irritable, muscle spasms occur, and the patient experiences abdominal pain and fever. If the sacs continue to enlarge, they may rupture into the peritoneum, giving rise to peritonitis, an inflammation of the peritoneum. More commonly they fix themselves to neighbouring organs and produce localized abscesses, which may prove difficult to treat surgically. Mild diverticulitis responds well to antibiotics; massive hemorrhages often require emergency surgery. Recurrent diverticulitis requires resection of the affected area of the colon.

Abscess: Abscesses (cavities of pus formed from disintegrating tissue) in the perianal area are common complicating features of many diseases and disorders of the large intestine. Fungal infections of the moist and sometimes poorly cleansed area around the anus are common and permit the maceration (or gradual breaking down) of tissue and invasion by bacteria from the skin and colon. In diabetics, who are susceptible to skin infection, perianal hygiene is very important.

Bacterial infections: The colon may become inflamed because of invasion by pathogenic, or disease-causing, bacteria or parasites. A variety of species of Shigella, for example, attack the mucous membrane of the colon and produce an intense but rather superficial hemorrhage. In infants and in the elderly, the amount of fluid and protein lost by the intense inflammatory response may be fatal, but ordinarily such symptoms are less serious in otherwise healthy persons. Salmonella species, responsible for severe generalized infections originating from invasion of the small intestine, may damage the lymph follicles of the colon, but they do not produce a generalized inflammation of the colon (colitis). The cytomegalic virus, on the other hand, can cause a severe colitis, producing ulcerations. Lymphopathia venereum causes a more generalized and superficial colitis.

Food residues provide an excellent culture medium for bacteria, and the interior of the colon is a nearly ideal environment for their growth. The most widely distributed parasite producing disease in the colon is the protozoan Entamoeba histolytica. This parasite enters the digestive tract via the mouth and lodges in the cecum and ascending colon. This usually results in irritability of the ascending colon and failure to absorb water properly, so that intermittent, watery diarrhea ensues. The amoebas undermine the mucosal coat and may create large ulcerations that bleed excessively. Stools contain blood, but there is little pus or other evidence of reaction by the colon to the invading organism. In more generalized amoebic colitis, the rectum and sigmoid colon are invaded by E. histolytica, which manifest their presence by numerous discrete ulcerations separated from each other by a relatively normal-appearing mucous membrane. The amoebas may enter the portal circulation and be carried to the liver, where abscesses form and sometimes rupture into the chest or the abdominal cavity. Immunologic tests of the blood may help in diagnosis. After identification of the parasites by direct smear tests from the margin of the ulcers or from the stools, a combination of amoebicidal drugs and a broad-spectrum antibiotic—i.e., an antibiotic that is toxic to a wide variety of parasites, usually metronidazole and tetracycline—is administered.

Colitis: The most common form of chronic colitis (inflammation of the colon) in the Western world, ulcerative colitis, is idiopathic (i.e., of unknown cause). Ulcerative colitis varies from a mild inflammation of the mucosa of the rectum, giving rise to excessive mucus and some spotting of blood in the stools, to a severe, sudden illness, with destruction of a large part of the colonic mucosa, considerable blood loss, toxemia and, less commonly, perforation. The most common variety affects only the rectum and sigmoid colon and is characterized by diarrhea and the passage of mucus. Ulcerative colitis tends to follow a remitting-relapsing course. Diagnosis is determined by performing a colonoscopy or a biopsy.

Another type of colitis arises when antibiotic use causes the abnormal proliferation of certain types of bacteria in the colon, leading to inflammation. This disorder is treated by stopping the use of the causal antibiotic and administering others such as vancomycin or mexronidazole. About 15 percent of all cases of colitis involve extension of the disease beyond the area initially affected, with an increase in severity. Where the destruction has been extensive, there is a risk of malignancy 10 to 20 years after the onset of the disease.

Crohn's disease: Crohn disease is characterized by chronic inflammation of the digestive tract, usually the terminal portion of the small intestine. The cause of Crohn disease is unknown. Apart from the greater tendency for fistulas to form and for the wall of the intestine to thicken until the channel is obstructed, it is only distinguishable from ulcerative colitis by microscopic findings. In Crohn disease, the maximum damage occurs beneath the mucosa, and lymphoid conglomerations, known as granulomata, are formed in the submucosa. Crohn disease attacks the perianal tissues more often than does ulcerative colitis. Although Crohn disease and ulcerative colitis are not common, they are disabling.

A combination of immunosuppressive and anti-inflammatory drugs, including corticosteroids and aminosalicylic acid compounds, are used to treat Crohn disease. The drugs are effective both in treating acute episodes and in suppressing the disease over the long term. Depending on the circumstances, hematinics, vitamins, high-protein diets, and blood transfusions are also used. Surgical resection of the portion of the large bowel affected is often performed. The entire colon may have to be removed and the small intestine brought out to the skin as an ileostomy, an opening to serve as a substitute for the anus. In ulcerative colitis, as opposed to Crohn disease, the rectal muscle may be preserved and the ileum brought through it and joined to the anus.

Cancer of Large intestine: In the Western world, colon cancer is more common than is stomach cancer, and it occurs about equally in both sexes. Risk factors for colon cancer include age, diets that are high in fat and low in fibre, a personal or family history of cancer, and the presence of polyps or ulcerative colitis. Symptoms are highly variable, the main feature being blood in the stools, but this may be detectable only by chemical testing. Cancers compress the colonic lumen to produce obstruction, they attach to neighbouring structures to produce pain, and they perforate to give rise to peritonitis. Cancers also may metastasize to distant organs before local symptoms appear. Nevertheless, the prognosis for patients with this cancer is considerably better than it is for cancer of the stomach. Some patients require a colostomy, in which an opening is made from the colon to the skin, where the fecal contents are extruded. After the colon has been removed partially, it is possible to join the terminal ileum or the remnant colon directly to the anal canal. A reservoir also can be fashioned out of the terminal ileum and placed inside the rectum muscle from which the inflamed mucosa has been removed. This functions as a normal rectum, and with retained sphincters at the anus, can render the patient continent, although there usually are three or four bowel movements daily.

AIDS is a transmissible disease of the immune system caused by the human immunodeficiency virus (HIV). HIV is a lentivirus (literally meaning "slow virus"; a member of the retrovirus family) that slowly attacks and destroys the immune system, the body's defense against infection, leaving an individual vulnerable to a variety of other infections and certain malignancies that eventually cause death. AIDS is the final stage of HIV infection, during which time fatal infections and cancers frequently arise.


THE EMERGENCE OF HIV/AIDS

Details of the origin of HIV remain unclear; however, a lentivirus that is genetically similar to HIV has been found in chimpanzees in western equatorial Africa. This virus, known as simian immunodeficiency virus (SIV), does not readily cause disease in chimpanzees. However, AIDS is a zoonosis, an infection that is shared by humans and lower vertebrate animals. The practice of hunting, butchering, and eating the meat of chimpanzees may have allowed transmission of the virus to humans, probably in the first half of the 20th century.

Genetic studies of two different types of HIV—HIV-1 and HIV-2—demonstrate that the viruses diverged from one another in the 1930s. Researchers estimate that the spread of HIV began in central and western Africa in the late 1950s, with HIV-1 being the predominant infectious form. Later, in the mid-1960s, a subtype of HIV-1 spread from Africa to Haiti. In Haiti this subtype acquired unique characteristics, presumably through the process of genetic recombination. Sometime between 1969 and 1972, the virus migrated from Haiti to the United States. The virus spread within the United States for about a decade before it was discovered in the early 1980s. The worldwide spread of HIV-1 was likely facilitated by several factors, including increasing urbanization and long-distance travel in Africa, international travel, changing sexual mores, and intravenous drug use.

In 1981 investigators in New York and California reported the first official case of AIDS. Initially, most cases of AIDS in the United States were diagnosed in homosexual men, who contracted the virus primarily through sexual contact, and in intravenous drug users, who became infected mainly by sharing contaminated hypodermic needles. In 1983 French and American researchers isolated the causative agent, HIV, and by 1985 serological tests to detect the virus had been developed. According to the 2007 United Nations report on AIDS, an estimated 33.2 million people were living with HIV, approximately 2.5 million people were newly infected with HIV, and about 2.1 million people died of AIDS. Relative to previous years, the statistics for 2007 reflect a decrease in the annual number of new infections and deaths from AIDS and an increase in the overall number of people living with AIDS. Some 25 million people have died of the disease since 1981.

People living in sub-Saharan Africa account for about 70 percent of all infections, and in some countries of the region the prevalence of HIV infection of inhabitants exceeded 10 percent of the population. Rates of infection are lower in other parts of the world, but different subtypes of the virus have spread to Europe, India, South and Southeast Asia, Latin America, and the Caribbean. Rates of infection have leveled off somewhat in the United States and Europe. In the United States nearly one million people are living with HIV/AIDS, and half of all new infections are among African Americans. In Asia the sharpest increases in HIV infections are found in China, Indonesia, and Vietnam. Access to retroviral treatment for AIDS remains limited in some areas of the world, although more people are receiving treatment today than in the past.

GROUPS AND SUBTYPES OF HIV

Genetic studies have led to a general classification system for HIV that is primarily based on the degree of similarity in viral gene sequence. HIV-1 is divided into three groups, known as group M (main group), group O (outlier group), and group N (new group). Worldwide, HIV-1 group M causes the majority of HIV infections, and it is further subdivided into subtypes A through K, which differ in expression of viral genes, virulence, and mechanisms of transmission. In addition, some subtypes combine with one another to create recombinant subtypes. HIV-1 group M subtype B is the virus that spread from Africa to Haiti and eventually to the United States. Pandemic forms of subtype B are found in North and South America, Europe, Japan, and Australia. Subtypes A, C, and D are found in sub-Saharan Africa, although subtypes A and C are also found in Asia and some other parts of the world. Most other subtypes of group M are generally located in specific regions of Africa, South America, or Central America.

HIV-2 is divided into groups A through E, with subtypes A and B being the most relevant to human infection. HIV-2, which is found primarily in western Africa, can cause AIDS, but it does so more slowly than HIV-1. There is some evidence that HIV-2 may have arisen from a form of SIV that infects African green monkeys.

PREVALENCE OF AIDS

AIDS is one of the deadliest epidemics in human history. It was first identified in 1981 among homosexual men and intravenous drug users in New York and California. Shortly after its detection in the United States, evidence of AIDS epidemics grew among heterosexual men, women, and children in sub-Saharan Africa. AIDS quickly developed into a worldwide epidemic, affecting virtually every nation. The United Nations Program on HIV/AIDS (UNAIDS) estimates that the worldwide number of new cases of HIV infection peaked in the late 1990s with more than 3 million people newly infected each year. However, some regions of the world, especially Vietnam, Indonesia, and other countries in southeast Asia, continued to see an increase in the early 2000s. In addition, the number of people living with HIV or AIDS has continued to rise as the result of new drug treatments that lengthen life.


While cases of AIDS have been reported in every nation of the world, the disease affects some countries more than others. About 90 percent of all HIV-infected people live in the developing world. AIDS has struck sub-Saharan Africa particularly hard. Two-thirds of all people living with HIV infection reside in African countries south of the Sahara, where AIDS is the leading cause of death.

In countries hardest hit, AIDS has sapped the population of young men and women who form the foundation of the labor force. Most die while in the peak of their reproductive years. Moreover, the epidemic has overwhelmed health-care systems, increased the number of orphans, and caused life expectancy rates to plummet. These problems have reached crisis proportions in parts of the world already burdened by war, political upheaval, or unrelenting poverty.

CAUSE OF AIDS

AIDS is the final stage of a chronic infection with the human immunodeficiency virus. There are two types of this virus: HIV-1, which is the primary cause of AIDS worldwide, and HIV-2, found mostly in West Africa. Inside the body HIV enters cells of the immune system, especially white blood cells known as T cells. These cells orchestrate a wide variety of disease-fighting mechanisms. Particularly vulnerable to HIV attack are specialized "helper" T cells known as CD4 cells. When HIV infects a CD4 cell, it commandeers the genetic tools within the cell to manufacture new HIV virus. The newly formed HIV virus then leaves the cell, destroying the CD4 cell in the process. No existing medical treatment can completely eradicate HIV from the body once it has infected human cells.

The loss of CD4 cells endangers health because these cells help other types of immune cells respond to invading organisms. The average healthy person has over 1,000 CD4 cells per microliter of blood. In a person infected with HIV, the virus steadily destroys CD4 cells over a period of years, diminishing the cells’ protective ability and weakening the immune system. When the density of CD4 cells drops to 200 cells per microliter of blood, the infected person becomes vulnerable to AIDS-related opportunistic infections and rare cancers, which take advantage of the weakened immune defenses to cause disease.

LIFE CYCLE OF HIV VIRUS

The main cellular target of HIV is a special class of white blood cells critical to the immune system known as helper T lymphocytes, or helper T cells. Helper T cells are also called CD4+ T cells because they have on their surfaces a protein called CD4. Helper T cells play a central role in normal immune responses by producing factors that activate virtually all the other immune system cells. These include B lymphocytes, which produce antibodies needed to fight infection; cytotoxic T lymphocytes, which kill cells infected with a virus; and macrophages and other effector cells, which attack invading pathogens. AIDS results from the loss of most of the helper T cells in the body.

HIV is a retrovirus, one of a unique family of viruses that consist of genetic material in the form of RNA (instead of DNA) surrounded by a lipoprotein envelope. HIV cannot replicate on its own and instead relies on the mechanisms of the host cell to produce new viral particles. HIV infects helper T cells by means of a protein embedded in its envelope called gp120. The gp120 protein binds to a molecule called CD4 on the surface of the helper T cell, an event that initiates a complex set of reactions that allow the HIV genetic information into the cell. Entry of HIV into the host cell also requires the participation of a set of cell surface proteins that normally serve as receptors for chemokines (hormone-like mediators that attract immune system cells to particular sites in the body). It appears that the binding of gp120 to CD4 exposes a region of gp120 that interacts with the chemokine receptors. This interaction triggers a conformational change that exposes a region of the viral envelope protein gp41, which inserts itself into the membrane of the host cell so that it bridges the viral envelope and the cell membrane. An additional conformational change in gp41 pulls these two membranes together, allowing fusion to occur. After fusion the viral genetic information can enter the host cell.

Once the virus has infected a T cell, HIV copies its RNA into a double-stranded DNA copy by means of the viral enzyme reverse transcriptase; this process is called reverse transcription because it violates the usual way in which genetic information is transcribed. Because reverse transcriptase lacks the "proofreading" function that most DNA synthesizing enzymes have, many mutations arise as the virus replicates, further hindering the ability of the immune system to combat the virus. These mutations allow the virus to evolve very rapidly, approximately one million times faster than the human genome evolves. This rapid evolution allows the virus to escape from antiviral immune responses and antiretroviral drugs. The next step in the virus life cycle is the integration of the viral genome into the host cell DNA. Integration occurs at essentially any accessible site in the host genome and results in the permanent acquisition of viral genes by the host cell. Under appropriate conditions these genes are transcribed into viral RNA molecules. Some viral RNA molecules are incorporated into new virus particles, while others are used as messenger RNA for the production of new viral proteins. Viral proteins assemble at the plasma membrane together with the genomic viral RNA to form a virus particle that buds from the surface of the infected cell, taking with it some of the host cell membrane that serves as the viral envelope. Embedded in this envelope are the gp120/gp41 complexes that allow attachment of the helper T cells in the next round of infection. Most infected cells die quickly (in about one day). The number of helper T cells that are lost through direct infection or other mechanisms exceeds the number of new cells produced by the immune system, eventually resulting in a decline in the number of helper T cells. Physicians follow the course of the disease by determining the number of helper T cells (CD4+ cells) in the blood. This measurement, called the CD4 count, provides a good indication of the status of the immune system. Physicians also measure the amount of virus in the bloodstream—i.e., the viral load—which provides an indication of how fast the virus is replicating and destroying helper T cells.

Because of the high rate at which the genetic material of HIV mutates, the virus in each infected individual is slightly different. Genetic variants of HIV have been categorized into several major subtypes, or clades, which have different geographical distributions. Variation occurs throughout the genome but is especially pronounced in the gene encoding the gp120 protein. By constantly changing the structure of its predominant surface protein, the virus can avoid recognition by antibodies produced by the immune system.

HOW HIV INFECTION SPREADS

Scientists have identified three ways that HIV infections spread: sexual intercourse with an infected person, contact with contaminated blood, and transmission from an infected mother to her child before or during birth or through breast-feeding.

1. Sex with an Infected Person: HIV transmission occurs most commonly during intimate sexual contact with an infected person, including genital, anal, and oral sex. The virus is present in the infected person’s semen or vaginal fluids. During sexual intercourse, the virus gains access to the bloodstream of the uninfected person by passing through openings in the mucous membrane—the protective tissue layer that lines the mouth, vagina, and rectum—and through breaks in the skin of the penis. In the United States and Canada, HIV is most commonly transmitted during sex between men, but the incidence of HIV transmission between men and women has rapidly increased. In most other parts of the world, HIV is most commonly transmitted through heterosexual sex.


2. Contact with Infected Blood: Direct contact with HIV-infected blood occurs when people who use heroin or other injected drugs share hypodermic needles or syringes contaminated with infected blood. Sharing of contaminated needles among intravenous drug users has been a primary cause of HIV infection in parts of eastern Europe and central Asia.


Less frequently, HIV infection results when health professionals accidentally stick themselves with needles containing HIV-infected blood or expose an open cut to contaminated blood. Some cases of HIV transmission from transfusions of infected blood, blood components, and organ donations were reported in the 1980s. Since 1985 government regulations in the United States and Canada have required that all donated blood and body tissues be screened for the presence of HIV before being used in medical procedures. As a result of these regulations, HIV transmission caused by contaminated blood transfusion or organ donations is rare in North America. However, the problem continues to concern health officials in sub-Saharan Africa.

3. Mother-to-Child Transmission: HIV can be transmitted from an infected mother to her baby while the baby is still in the woman’s uterus or, more commonly, during childbirth. The virus can also be transmitted through the mother’s breast milk during breast-feeding. Mother-to-child transmission accounts for 90 percent of all cases of AIDS in children. Mother-to-child transmission is particularly prevalent in Africa.


4. Misperceptions About HIV Transmission: The routes of HIV transmission are well documented by scientists, but health officials continually grapple with people’s unfounded fears concerning the potential for HIV transmission by other means. HIV differs from other infectious viruses in that it dies quickly if exposed to the environment. No evidence has linked HIV transmission to casual contact with an infected person, such as a handshake, hugging, or kissing, or even sharing dishes or bathroom facilities. Studies have been unable to identify HIV transmission from modes common to other infectious diseases, such as an insect bite or inhaling virus-infected droplets from an infected person’s sneeze or cough.



SYMPTOMS OF AIDS

Without medical intervention, AIDS progresses along a typical course. Within one to three weeks after infection with HIV, most people experience flu-like symptoms, such as fever, sore throat, headache, skin rash, tender lymph nodes, and a vague feeling of discomfort. These symptoms last one to four weeks. During this phase, known as acute retroviral syndrome, HIV reproduces rapidly in the blood. The virus circulates in the blood throughout the body, particularly concentrating in organs of the lymphatic system.

The normal immune defenses against viral infections eventually activate to battle HIV in the body, reducing but not eliminating HIV in the blood. Infected individuals typically enter a prolonged asymptomatic phase, a symptom-free period that can last ten years or more. While persons who have HIV may remain in good health during this period, HIV continues to replicate, progressively destroying the immune system. Often an infected person remains unaware that he or she carries HIV and unknowingly transmits the virus to others during this phase of the infection.

When HIV infection reduces the number of CD4 cells from around 500 to 200 per microliter of blood, the infected individual enters an early symptomatic phase that may last a few months to several years. HIV-infected persons in this stage may experience a variety of symptoms that are not life-threatening but may be debilitating. These symptoms include extensive weight loss and fatigue (wasting syndrome), periodic fever, recurring diarrhea, and thrush, a fungal mouth infection. An early symptom of HIV infection in women is a recurring vaginal yeast infection. Unlike earlier stages of the disease, in this early symptomatic phase the symptoms that develop are severe enough to cause people to seek medical treatment. Many may first learn of their infection in this phase.

A. Opportunistic Infections


If CD4 cell levels drop below 200 cells per microliter of blood, the late symptomatic phase develops. This phase is characterized by the appearance of any of the opportunistic infections and rare cancers known as AIDS-defining conditions. The onset of these illnesses is a sign that an HIV-infected person has developed full-blown AIDS. Without medical treatment, this stage may last from several months to years. The cumulative effects of these illnesses usually cause death.
Often the first opportunistic infection to develop is pneumocystis pneumonia, a lung infection caused by the fungus Pneumocystis carinii. This fungus infects most people in childhood, settling harmlessly in the lungs where it is prevented from causing disease by the immune system. But once the immune system becomes weakened, the fungus can block the lungs from delivering sufficient oxygen to the blood. The lack of oxygen leads to severe shortness of breath accompanied by fever and a dry cough.

In addition to pneumocystis pneumonia, people with AIDS often develop other fungal infections. Up to 23 percent of people with AIDS become infected with fungi from the genus Cryptococcus, which cause meningitis, inflammation of the membranes that surround the brain. Infection by the fungus Histoplasma capsulatum affects up to 10 percent of people with AIDS, causing general weight loss, fever, and respiratory complications.

Tuberculosis, a severe lung infection caused by the bacterium Mycobacterium tuberculosis, typically becomes more severe in AIDS patients than in those with a healthy immune system. Between the 1950s and the late 1980s, tuberculosis was practically eradicated in North America. In the early 1990s, doctors became alarmed when incidence of the disease dramatically escalated. This resurgence was attributed to the increased susceptibility to tuberculosis of people infected with HIV. Infection by the bacterium Mycobacterium avium can cause fever, anemia, and diarrhea. Bacterial infections of the gastrointestinal tract contribute to wasting syndrome.

Opportunistic infections caused by viruses, especially members of the herpesvirus family, are common in people with AIDS. One of the herpesviruses, cytomegalovirus (CMV), infects the retina of the eye and can result in blindness. Another herpesvirus, Epstein-Barr virus (EBV), may cause certain types of blood cancers. Infections with herpes simplex virus (HSV) types 1 or 2 may result in sores around the mouth, genital area, or anus.

Many people with AIDS develop cancers. The destruction of CD4 cells impairs the immune functions that halt the development of cancer. Kaposi’s sarcoma is a cancer of blood vessels caused by a herpesvirus. This cancer produces purple lesions on the skin, which can spread to internal organs and cause death. B cell lymphoma affects certain cells of the lymphatic system that fight infection and perform other vital functions. Cervical cancer is more common in HIV-infected women than in women free from infection.

A variety of neurological disorders are common in the later stage of AIDS. Collectively called HIV-associated dementia, they develop when HIV or another microbial organism infects the brain. The infection produces degeneration of intellectual processes such as memory and, sometimes, problems with movement and coordination.

B. Symptoms in Children


HIV infection in children progresses more rapidly than in adults, most likely because a child’s immune system has not yet built up immunity to many infectious agents. The disease is particularly aggressive in infants—more than half of infants born with an HIV infection die before age two. Once a child is infected, the child’s undeveloped immune system cannot prevent the virus from multiplying quickly in the blood, and the disease progresses rapidly. In contrast, when an adult becomes infected with HIV, the adult’s immune system generally fights the infection. Therefore, HIV levels in adults remain lower for an extended period, delaying the progression of the disease.

Children develop many of the opportunistic infections that befall adults but also exhibit symptoms not observed in older patients. Among infants and children, HIV infection produces wasting syndrome and slows growth (generally referred to as failure to thrive). HIV typically infects a child’s brain early in the course of the disease, impairing intellectual development and coordination skills. While HIV can infect the brains of adults, it usually does so toward the later stages of the disease and produces different symptoms.

Children show a susceptibility to more bacterial and viral infections than adults. More than 20 percent of HIV-infected children develop serious, recurring bacterial infections, including meningitis and pneumonia. Some HIV-infected children suffer from repeated bouts of viral infections, such as chicken pox. Healthy children generally develop immunity to these viral illnesses after an initial infection.


DETECTING AND MONITORING HIV INFECTION

Since HIV was first identified as the cause of AIDS in 1983, a variety of tests have been developed that help diagnose HIV infection as well as determine how far the infection has progressed. Other tests can be used to screen donated blood, blood products, and body organs for the presence of HIV.

Doctors determine if HIV is present in the body by identifying HIV antibodies, specialized proteins created by the immune system to destroy HIV. The presence of these antibodies indicates HIV infection because they form in the body only when HIV is present. HIV antibodies form anywhere from five weeks to three months after HIV infection occurs, depending upon the individual’s immune system. The antibodies are produced continually throughout the course of the infection.

The standard test to detect HIV antibodies in the blood is the enzyme-linked immunosorbent assay (ELISA). In this test, a blood sample is mixed with proteins from HIV. If the blood contains HIV antibodies, they attach to the HIV proteins, producing a telltale color change in the mixture. This test is highly reliable when performed two to three months after infection with HIV. The test is less reliable when used in the very early stage of HIV infection, before detectable levels of antibodies have had a chance to form. Doctors routinely confirm a positive result from an ELISA test by using the Western Blot test, which can detect lower levels of HIV antibodies. In this test a blood sample is applied to a paper strip containing HIV proteins. If HIV antibodies are present in the blood, they bind to the HIV proteins, producing a color change on the paper. The combination of the ELISA and the Western Blot test is more than 99.9 percent accurate in detecting HIV infection within 12 weeks following exposure.

Once tests confirm an HIV infection, doctors monitor the health of the infected person’s immune system by periodically measuring CD4 cell counts in the blood. The progressive loss of CD4 cells corresponds to a worsening of the disease as the immune system becomes increasingly impaired. Doctors also measure the viral load—the amount of the virus in the blood—using polymerase chain reaction (PCR) technology. PCR tests measure the level of viral ribonucleic acid (RNA), or HIV particles, in an infected person’s blood to determine how actively the virus is replicating and how fast the disease is progressing. Knowing the viral load helps doctors make decisions about the treatment and its effectiveness.

A modified ELISA test that detects p24 antigen, a protein produced by HIV, can determine if specific drug treatments are having a positive effect on a patient. Blood banks, plasma centers, clinical laboratories, private clinics, and public health departments also use this p24 antigen test to screen for the presence of HIV in blood, blood components, and organs before they are used in medical procedures.


DIAGNOSING AIDS

Physicians prefer to differentiate between people who have HIV infection and those who have AIDS. The Centers for Disease Control and Prevention (CDC), based in Atlanta, Georgia, recommends that physicians reserve the diagnosis of AIDS for HIV-infected individuals whose CD4 count falls below 200 cells per microliter of blood. A diagnosis of AIDS can also be made without confirmation of CD4 levels if someone who has no other reason for immune system damage develops an opportunistic disease.


TREATMENT

While no medical treatment cures AIDS, in the relatively short time since the disease was first recognized, new methods to treat the disease have developed rapidly. Health-care professionals focus on three areas of therapy for people living with HIV infection or AIDS: antiretroviral therapy using drugs that suppress HIV replication; medications and other treatments that fight the opportunistic infections and cancers that commonly accompany HIV infection; and support mechanisms that help people deal with the emotional repercussions as well as the practical considerations of living with a disabling, potentially fatal disease.


A. Antiretroviral Therapies

Understanding the specific steps in the HIV replication cycle is critical in order for scientists to develop drugs that attack vulnerable stages within the cycle. HIV belongs to a unique group of viruses known as retroviruses, so named because these viruses reverse the usual flow of genetic information within an infected cell. Most viruses store their genetic material in deoxyribonucleic acid (DNA), the double-helix structure that makes up genes. When a virus infects a cell, the viral DNA forms the template for the creation of messenger RNA, a type of ribonucleic acid. This messenger RNA directs the formation of specific proteins, and these proteins, in turn, build new virus particles (see Genetics). In HIV, however, genetic material is stored in two single-stranded RNA molecules. When HIV infects a cell, an enzyme called reverse transcriptase copies the genetic instructions in the virus’s RNA and moves it into the DNA. This movement of genetic information from RNA to DNA is the opposite of that which occurs in most cells during protein synthesis.

Another HIV enzyme, called integrase, helps the newly formed viral DNA to become part of the structure of the infected cell’s DNA. The viral DNA then forces the infected cell to manufacture HIV particles. A third HIV enzyme, called protease, packages these HIV particles into a complete and functional HIV virus. Over the last decade researchers have created a variety of drugs that block the action of some of the enzymes used in HIV replication. The main classes of drugs used against HIV are nucleoside analogues, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and fusion inhibitors.

Nucleoside analogues (also called nucleoside reverse transcriptase inhibitors (NRTIs)) impede the action of reverse transcriptase, the HIV enzyme that converts the virus’s genetic material into DNA. During this conversion process, these drugs incorporate themselves into the structure of the viral DNA, rendering the DNA useless and preventing it from instructing the infected cell to make additional HIV. The nucleoside analogue known as azidothymidine (AZT), which became available in 1987, was the first drug approved by the United States Food and Drug Administration (FDA) to treat AIDS. AZT slows HIV growth in the body, permitting an increase in the number of CD4 cells, which boosts the immune system. AZT also prevents transmission of HIV from an infected mother to her newborn. Since the introduction of AZT, additional nucleoside analogues have been developed, including didanosine (sold under the trade name Videx), zalcitabine (Hivid), stavudine (Zerit), lamivudine (Epivir), abacavir (Ziagen), and emtricitabine (Emtriva). These drugs are not particularly powerful when used alone, and often their benefits last for only 6 to 12 months. But when nucleoside analogues are used in combination with each other, they provide longer-lasting and more effective results.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), introduced in 1996, use a different mechanism to block reverse transcriptase. These drugs bind directly to reverse transcriptase, preventing the enzyme from converting RNA to DNA. Three NNRTIs are available: nevirapine (Viramune), delavirdine (Rescriptor), and efavirenz (Sustiva). NNRTIs work best when used in combination with nucleoside analogues.

The third group of antiviral drugs, called protease inhibitors, cripples protease, the enzyme vital to the formation of new HIV. When these drugs block protease, the defective HIV that forms is unable to infect new cells. Protease inhibitors are more powerful than nucleosides and NNRTIs, producing dramatic decreases in HIV levels in the blood. This reduced viral load, in turn, enables CD4 cell levels to skyrocket. The first protease inhibitor, saquinavir (Invirase), was approved in 1995. Since then other protease inhibitors have been approved, including ritonavir (Norvir), indinavir (Crixivan), nelfinavir (Viracept), amprenavir (Agenerase), tipranavir (Aptivus), and darunavir (Prezista).

A class of drugs known as fusion inhibitors became available in 2003. That year the FDA approved the use of enfuvirtide, sold under the brand name Fuzeon. Fusion inhibitors prevent the binding or fusion of HIV to CD4 cells. When used with other antiretroviral medicines, fusion inhibitors can reduce the amount of HIV in the blood and increase the number of CD4 cells. A related drug, called an entry inhibitor, was introduced in 2007 as maraviroc (Selzentry). It, too, is designed to prevent HIV from infecting CD4 cells.

1. Drug Resistance:When a single antiretroviral drug is used alone, its benefits last only a short time, as clinical studies of treatments with the drugs soon demonstrated. This short-term effectiveness is due to mutation, or changes in the genetic structure, of HIV that makes the virus resistant to the drug. The genetic material in HIV provides instructions for the manufacture of critical enzymes needed to replicate the virus. Scientists design antiretroviral drugs to impede the activity of these enzymes. If the virus mutates, the structure of the virus’s enzymes changes and the drugs no longer work against the enzymes or the virus.


Genes mutate during the course of viral replication, so the best way to prevent mutation is to halt replication. Studies have shown that the most effective treatment for halting HIV replication employs a combination of three drugs taken together—for instance, a combination of two nucleoside analogues with a protease inhibitor. This regimen, called triple therapy, maximizes drug potency while reducing the chance for drug resistance. The combination of three drugs is often referred to as an AIDS cocktail. In HIV-infected patients who have undergone triple therapy, the viral loads reduced significantly, sometimes to undetectable levels. Their CD4 cell count gradually increased, and they sustained good health with no complications. With this treatment, some patients who were near death were able to return to work and normal physical activity. Triple therapy was introduced in the United States in 1996. That year AIDS deaths in the United States decreased 26 percent, the first decrease since the beginning of the epidemic. In 1997 U.S. AIDS deaths decreased by 56 percent from the year before.

Despite its success, triple therapy has had some drawbacks. This multidrug therapy has been quite complicated, requiring patients to take anywhere from 2 to 20 pills a day on a specific schedule. Some drugs must be taken with food, and some cannot be taken at the same time as other pills. Even the most organized people find it difficult to take the pills correctly. Yet, just one or two lapses in treatment may cause the virus to develop resistance to the drug regimen.

In July 2006 the FDA approved a new three-drug combination that can be taken as a single pill once a day with or without food. Marketed under the name Atripla, the new drug combines the existing drugs Sustiva (the NNRTI efavirenz) and Truvada (the NRTIs emtricitabine and tenofovir) in a special formulation. The product is seen as a breakthrough in AIDS and HIV treatment for its simplicity and convenience. The once-daily pill form should help patients take the drugs on a regular, uninterrupted schedule that will not allow the HIV in their bodies to develop resistance to the drugs. The new pill could prove particularly useful in developing countries, where following complex regimens of different AIDS drugs is often impractical.

Many people find it difficult to deal with the unpleasant side effects produced by antiretroviral drugs. Common side effects include nausea, diarrhea, headache, fatigue, abdominal pain, kidney stones, anemia, and tingling or numbness in the hands and feet. Some patients may develop diabetes mellitus, while other patients develop collections of fat deposits in the abdomen or back, causing a noticeable change in body configuration. Some antiretroviral drugs produce an increase in blood fat levels, placing a patient at risk for heart attack or stroke. Some patients suffer more misery from the drug treatment than they do from the illnesses produced by HIV infection.

Perhaps the greatest drawback to triple therapy has been its cost, which has ranged from $10,000 to $12,000 a year. This high cost is well beyond the means of people with low incomes or those with limited health-care insurance. As a result, the most effective therapies currently available have remained beyond the reach of the majority of HIV-infected people worldwide.

2. Postexposure Prevention: Studies show that under certain circumstances, administering antiretroviral drugs within 24 hours (preferably within one to two hours) after exposure to HIV can protect a person from becoming infected with the virus. Although the effectiveness of postexposure antiretroviral therapy following sexual exposure to HIV remains uncertain, the CDC recommends that health-care personnel exposed to HIV infection from a needle stick or other accident take antiretroviral drugs.



3. Development of New Drugs: Scientists continue to develop more powerful HIV treatments that have fewer side effects and fewer resistance problems. Some drugs under investigation block the HIV enzyme integrase from inserting viral DNA into the infected cell. Other drugs prevent HIV from binding with a CD4 cell in the first place, thereby barring HIV entry into cells.
Some scientists focus on ways to fortify the immune system. A biological molecule called interleukin-2 shows promise in boosting the immune system’s arsenal of infection-fighting cells. Interleukin-2 stimulates the production of CD4 cells. If enough CD4 cells can be created, they may trigger other immune cell responses that can overpower HIV infection.


In other research, doctors hope to bolster the immune system with a vaccine (see Immunization). Most vaccines available today, including those that prevent measles or poliomyelitis, work by helping the body to create antibodies. Such vaccines mark specific infectious agents, such as the measles and polio viruses, for destruction. But many experts believe that an effective HIV vaccine will need to do more than just stimulate anti-HIV antibodies. Studies are underway to develop vaccines that also elevate the production of T cells in the immune system. Scientists hope that this dual approach will prime the immune system to attack HIV as soon as it appears in the body, perhaps containing the virus before it spreads through the body in a way that natural immune defenses cannot. The genetic variability of HIV frustrates efforts to develop a vaccine: A vaccine effective against one type of HIV may not work on a virus that has undergone genetic mutation.

B. Treatment of Opportunistic Infections


In addition to antiretroviral therapy to combat HIV infection, effective drug treatments are available to fight many of the medical complications that result from HIV infection. Doctors try to prevent infections before they begin to avoid taxing a patient’s weakened immune system unnecessarily. A doctor instructs an HIV-infected person on ways to avoid exposure to infectious agents that produce opportunistic infections common in people with a weakened immune system. Doctors usually prescribe more than one drug to forestall infections. For example, for those who have a history of pneumocystic pneumonia and a CD4 cell count of less than 200 cells per microliter, doctors may prescribe the antibiotics sulfamethoxazole and trimethoprim to prevent further bouts of pneumonia. Patients suffering from recurring thrush may be given the antifungal drug fluconazole for prolonged periods. For people with CD4 cell counts of less than 100 cells per microliter, doctors may prescribe clarithromycin or azithromycin to prevent Mycobacterium avium infections.

C. Support mechanisms


A person diagnosed with HIV infection faces many challenges, including choosing the best course of treatment, paying for health care, and providing for the needs of children in the family while ill. In addition to these practical considerations, people with HIV infection must cope with the emotional toll associated with the diagnosis of a potentially fatal illness. The social stigma that continues to surround a diagnosis of AIDS because of the disease’s prevalence among gay men or drug users causes many people to avoid telling family or friends about their illness. People with AIDS often feel incredibly lonely as they try to cope with a devastating illness on their own. Loneliness, anxiety, fear, anger, and other emotions often require as much attention as the medical illnesses common to HIV infection.

Since the AIDS epidemic began in the United States in 1981, grassroots organizations have been created to meet the medical and emotional needs of people who have AIDS and also to protect their civil rights. The Gay Men’s Health Crisis, founded in 1982, was the first nonprofit organization to provide medical, education, and advocacy services for people with AIDS. The Los Angeles Shanti Group was established in 1983 to provide emotional support and medical guidance to people with AIDS and other life-threatening illnesses. Activist organizations such as the AIDS Coalition to Unleash Power (ACT UP), founded in 1986, have been created to initiate faster change in public policies and to speed up the course of AIDS clinical research. American Foundation for AIDS Research (AMFAR), created in 1985, is the nation’s leading nonprofit organization dedicated to the support of AIDS research and the advocacy of fair and compassionate AIDS-related public policies. In Canada, the AIDS Committee of Toronto (ACT) was established in 1983 by community activists intent on fighting for the civil rights of people infected with HIV. As the AIDS epidemic grew, ACT expanded its mission to help people disabled by the disease and to spread health information to halt the spread of the disease. AIDS Vancouver (AV), also established in 1983, became the principal education, prevention, and support service organization for that city.

Counseling centers and churches provide individual or group counseling to help people with HIV infection or AIDS share their feelings, problems, and coping mechanisms with others. Family counseling can address the emotions of other family members who are disturbed by the diagnosis of HIV infection in another family member. Grief counseling also helps people who have lost friends or family members to AIDS.


PREVENTION OF AIDS

With a vaccine for AIDS years away and no cure on the horizon, experts believe that the most effective treatment for AIDS is to prevent HIV infection. Health officials focus public education programs on altering risky behaviors linked to HIV transmission, particularly unsafe sexual practices and needle-sharing by intravenous drug users. Safe-sex campaigns sponsored by health clinics, social centers, schools, and churches encourage sexual abstinence or monogamy (sexual relations with only one partner). Education programs instruct about the proper way to use condoms to provide a protective barrier against transmission of HIV during sexual intercourse. Needle-exchange programs, which provide clean needles to drug users, enable intravenous drug abusers to avoid sharing HIV-contaminated needles. Needle-exchange programs have been widely criticized because they seem to condone illicit drug use. However, numerous U.S. government-funded studies have indicated that such programs reduce HIV transmission without promoting greater drug use. To reduce the accidental transmission of HIV during medical procedures, both the United States and Canada have established strict guidelines for health-care settings, including the use of protective clothing and proper instrument disposal.
In the United States, the effectiveness of public education programs that target people at risk for HIV infection was well demonstrated in the gay community of San Francisco, California, in the 1980s. In 1982 and 1983, 6,000 to 8,000 people in San Francisco became infected with HIV. The gay community rallied to promote condom use and advocate monogamy through extensive education programs and public health advertisements geared for gay men. These public education programs were credited with reducing the number of gay men in San Francisco who became HIV infected. By 1993 the number of new infections declined to 1,000, and by 1999, fewer than 500 people were infected each year.

Public education about AIDS has also proven effective in other countries. Uganda was one of the first African countries to report cases of HIV infection. The first cases of AIDS were reported there in 1982, and by the late 1980s Uganda had one of the highest rates of HIV infection in the world. The Ugandan government was one of the first countries to set up a partnership with WHO to create a national AIDS control program called the AIDS Information Centre (AIC). The AIC has established extensive education programs promoting condom use and other methods to prevent HIV from spreading further. The program has also worked with community organizations to change social behaviors that increase the risk of HIV infection. The AIC promotes its message using innovative drama, song, and dance programs, a particularly effective communication method for African communities. AIC established confidential HIV testing services that provide same-day results and community counseling programs. As a result of Uganda’s quick response to the AIDS epidemic, the number of HIV infected people in that country declined significantly after 1993, during a time when most other African nations faced a frightening increase in the incidence of HIV infection.

Public health officials have learned that education programs that teach and reinforce safe behaviors through a series of meetings are more effective than one-time exposure to public-health information provided in a class lecture, magazine article, advertisement, or pamphlet. Education programs tailored to reflect specific ethnic and cultural preferences prove even more effective. For example, the Canadian Aboriginal AIDS Network creates HIV education programs that fight the common misperception among the indigenous peoples of Canada that AIDS is primarily a disease of white, affluent people. Among indigenous communities, the network promotes programs that use colloquial language to increase awareness about safe sex practices and needle use.

Another recently proposed approach to AIDS prevention is development of simple microbicidal creams or gels that women could use before sex to reduce the risk of HIV infection. Such topical anti-HIV products would be especially useful in developing countries where women may not have access to other forms of protection such as condoms. Currently, a number of different products are undergoing clinical trials in Africa.

Research conducted in Africa demonstrated that male circumcision could reduce by more than half a man’s risk of contracting AIDS through heterosexual intercourse. The findings were announced by the U.S. National Institutes of Health in 2006. They were not expected to affect AIDS prevention strategies in the United States, where most men are circumcised. However, adult circumcision could be a prevention strategy in developing countries where circumcision is less common. Male circumcision also lowers the risk of transmitting AIDS to women, but its effect on AIDS risk for men who have sex with men is not yet known.


SOCIAL PERSPECTIVES ON AIDS

Although new and effective AIDS drugs have brought hope to many HIV-infected persons, a number of social and ethical dilemmas still confront researchers and public-health officials. The latest combination drug therapies are far too expensive for infected persons in the developing world—particularly in sub-Saharan Africa, where the majority of AIDS deaths have occurred. In these regions, where the incidence of HIV infection has soared, the lack of access to drugs can be catastrophic.

A. Testing AIDS Drugs and Vaccines


AIDS research in the developing world has raised ethical questions pertaining to the clinical testing of new therapies and potential vaccines. For example, controversy erupted over 1997 clinical trials that tested a shorter course of AZT therapy in HIV-infected pregnant women in developing countries. Earlier studies had shown that administering AZT to pregnant women for up to six months prior to birth could cut mother-to-child transmission of HIV by up to two-thirds. The treatment’s $800 cost, however, made it too expensive for patients in developing nations.

The controversial 1997 clinical trials, which were conducted in Thailand and other regions in Asia and Africa, tested a shorter course of AZT treatment, costing only $50. Some pregnant women received AZT, while others received a placebo—a medically inactive substance often used in drug trials to help scientists determine the effectiveness of the drug under study. Ultimately the shorter course of AZT treatment proved to be successful and is now standard practice in a growing number of developing nations. However, at the time of the trials, critics charged that using a placebo on HIV-infected pregnant women—when AZT had already been shown to prevent mother-to-child transmission—was unethical and needlessly placed babies at fatal risk. Defenders of the studies countered that a placebo was necessary to accurately gauge the effectiveness of the AZT short-course treatment. Some critics speculated whether such a trial, while apparently acceptable in the developing nations of Asia and Africa, would ever have been viewed as ethical, or even permissible, in a developed nation like the United States.

Similar ethical questions surround the testing of AIDS vaccines in developing nations. Vaccines typically use weakened or killed HIV to spark antibody production. In some vaccines, these weakened or killed viruses have the potential to cause infection and disease. Critics have questioned whether it is ethical to place all the risk on test subjects in developing regions such as sub-Saharan Africa, where a person infected by a vaccine would have little or no access to medical care. At the same time, with AIDS causing up to 5,500 deaths a day in Africa, others feel that developing nations must pursue any medical avenue for stemming the epidemic and protecting people from the virus.

B. Economic Burden


For the struggling economies of some developing nations, AIDS has brought yet another burden: AIDS tends to kill young adults in the prime of their lives—the primary breadwinners and caregivers in families. According to figures released by the United Nations in 1999, AIDS has shortened the life expectancy in some African nations by an average of seven years. In Zimbabwe, life expectancy for adults declined from 61 years in 1993 to 38 in 2003, according to the World Health Organization (WHO). The next few decades may see average life expectance fall even lower in sub-Saharan Africa. Millions of children around the world have been orphaned by the AIDS epidemic. Those children who survive face poverty, a high risk of malnutrition and disease, and the absence of a family support structure.

In Africa, the disease has had a heavy impact on urban professionals—educated, skilled workers who play a critical role in the labor force of industries such as agriculture, education, transportation, and government. The decline in the skilled workforce has already damaged economic growth in Africa, and economists warn of disastrous consequences in the future.

C. Social stigma and discrimination


From the early days of the identification of AIDS, the disease has been powerfully linked to behaviors that are illegal (such as illicit drug use) or are considered immoral by many people (such as promiscuity and homosexuality). Consequently, a diagnosis of AIDS was a mark of disgrace, although medical research revealed that the disease follows well-defined modes of transmission that can affect any person. As the extent of the epidemic unfolded, misinformation about AIDS and how it is transmitted triggered widespread fear of contracting the disease. Some communities responded with hysteria that resulted in violence. In the United States, a Florida family with three HIV-positive sons who had become infected from blood transfusions were driven from their home when it was torched by an arsonist in 1987. In other communities, parents protested when HIV-infected children attended school. In many areas of the world, women in particular may face consequences if their HIV status is discovered. Reports indicate that many HIV-infected women are subject to domestic violence at the hands of their husbands—even if the husbands themselves are the source of infection. As a result, some women in developing nations fear being tested for HIV infection and cut themselves off from medical care and counseling.

In addition to social stigma, people infected with HIV must grapple with more immediate concerns—a daily struggle for basic medical care and other basic rights in the face of discrimination and fear because of their HIV status. In some places, nurses and other medical personnel who fear infection refuse to perform procedures on HIV-infected people. In 1998 the United States Supreme Court heard the case of Sidney Abbott, a young woman in Maine who sued dentist Randon Bragdon after he refused to treat her when he learned of her HIV-positive status. Basing its ruling on the Americans with Disabilities Act, the Supreme Court ruled in Bragdon v. Abbott that the woman’s HIV infection constituted a disability, even though she suffered from no disease symptoms. AIDS advocates expect this decision to protect the rights of many people with AIDS in the United States.

Some developing nations, such as Uganda, have met the AIDS crisis head-on, attempting to educate citizens and change high-risk behaviors in the population. However, other nations have been slow to even acknowledge the disease. In India, for example, the nation’s prime minister did not speak publicly about the dangers posed by the epidemic until 1999. In developed nations, some of the stigma attached to a diagnosis of AIDS has lessened in recent years, in part due to the admissions by public figures and celebrities, especially in the United States, that they were HIV-infected. The deaths from AIDS of actor Rock Hudson and tennis player Arthur Ashe, and the AIDS advocacy roles of basketball player Magic Johnson and Olympic diver Greg Louganis have personalized the disease and helped society come to terms with the enormity of the epidemic.

To some scientists, the AIDS epidemic signals a troubling trend in humanity’s future. Along with other deadly microbial threats of recent years—most notably Ebola virus, which has caused sporadic epidemics in Africa, and hantavirus, which broke out in the American Southwest in the early 1990s—AIDS is viewed by some as yet another in a series of emerging diseases that demonstrate how vulnerable humans are to newly encountered microbes. With population and land development increasing, humans have encroached farther into rain forests and other formerly wild areas, unleashing previously unknown disease agents. Meanwhile, global travel has become faster, more convenient, and more accessible to many people. Some scientists are worried by these trends, fearing the potential for an as-yet-unknown pathogen to arise and spread quickly and lethally around the globe.

The social, ethical, and economic effects of the AIDS epidemic are still being played out, and no one is entirely certain what the consequences will be. Despite the many grim facts of the AIDS epidemic, however, humanity is armed with proven, effective weapons against the disease: knowledge, education, prevention, and the ever-growing store of information about the virus’s actions.